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ABSTRACT 
Acute inflammatory response is caused by the rapid recruitment of leukocytes, mainly 
neutrophils and monocytes, from blood to the tissue site. Diverse agents, including 
invading pathogens, injured or dead cells, and other irritants, may stimulate this 
response.  In the ensuing inflammatory response, the recruited leukocytes and their 
secreted molecules help in eliminating or containing the injurious agents and promoting 
tissue regeneration. But often this response is imprecise and can lead to bystander tissue 
damage. Unchecked neutrophil activation is implicated in the pathology of many 
inflammatory conditions.  An in-depth understanding of the pathways regulating this 
response, therefore, becomes critical in identifying therapeutic targets for these diseases. 
In this study, we investigate the role of intestinal commensal bacteria in regulating the 
acute inflammatory response. Furthermore, we examine the mechanism by which 
Interleukin-1 (IL-1) controls the inflammatory response to sterile agents.  
Inflammatory responses have been studied in the context of host defense against 
pathogens.  However, we report that the innate immune system needs to be primed by 
intestinal flora to enable neutrophil recruitment to diverse microbial or sterile 
inflammatory signals. This priming requires myeloid differentiation primary response 
gene (88) (MyD88) signaling.  In antibiotic-treated mice, which have depleted intestinal 
flora, we show that  neutrophils get released into the blood from the bone marrow, but 
have a specific defect in migration into the inflammed tissue. This deficiency can be 
restored by pre-stimulating the mice with a purified MyD88 ligand. Despite having 
reduced number of infiltrating neutrophils, antibiotic-treated mice make higher levels of 
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pro-inflammatory cytokines in the tissue, after inflammatory challenge. This suggests 
that antibiotic-treated mice produce some anti-inflammatory molecule(s) that counteract 
the effect of the pro-inflammatory cytokines. However, this effect is not due to the 
overproduction of the anti-inflammatory cytokine, Interleukin-10 (IL-10).  In summary, 
our findings highlight the role of commensals in the development of acute inflammatory 
responses to microbial and sterile particles. 
The inflammatory response to sterile dead cells has been shown to be critically 
dependent upon IL-1. However, several key aspects of the IL-1 signaling cascade 
including the source of IL-1 and the cellular target of IL-1 were unresolved. We find that 
in most cases, the injured cells are not a major contributor of IL-1 that is required to 
propagate the inflammatory signal. On the contrary, we demonstrate that both the 
isoforms of IL-1, IL-1α/IL-1β are generated by bone marrow-derived, tissue-resident 
responding cells, upon sensing the injury. We also sought to determine the identity of 
the cellular target of IL-1 signaling. Previous studies have shown that for cell death-
induced neutrophil recruitment, interleukin-1 receptor (IL-1R) expression is required on 
parenchymal cells. To identify this parenchymal cell, we are currently in the process of 
making the conditional knockout mouse of IL-1R. The latter would facilitate the 
parenchymal tissue-specific deletion of IL-1R. In summary, this study reports our 
progress in unraveling key aspects of IL-1 signaling during sterile inflammation.  
Taken together, we have identified key modulators of the acute inflammatory response 
and their mechanisms of regulation. These findings would facilitate the development of 
new therapies for inflammatory diseases triggered by both microbe and sterile agents. 
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The central focus of this thesis is elucidating the molecular and cellular entities that 
regulate neutrophil migration and thus control the acute inflammatory response. 
Intriguingly, the symptoms of the inflammation response had been first recognized as 
early as 2000 years ago. However, the progress in identifying the molecular 
mechanisms underlying this response has happened only in the last twenty years. The 
findings in the current research add to our understanding of regulation of this response, 
by revealing the role of intestinal flora in the acute inflammatory response and 
interleukin-1 (IL-1) in the sterile inflammatory response.  
 
1. 1. OVERVIEW OF THE INFLAMMATORY RESPONSE 
 
1.1.1. The Acute Inflammatory Response 
Mammals develop an immediate and non-specific reaction to injury elicited by noxious 
agents. This reaction is called the acute inflammatory response. Pathologically, it 
involves a predetermined pattern of events characterized by changes in the 
microcirculation. This leads to increased passage of fluid out of the microcirculation 
and emigration of neutrophils into the site of injury. The infiltration of neutrophils 
occurs within minutes after the injury and is the hallmark of the acute inflammatory 
response. 
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1.1.2. Neutrophils: Warriors of the Inflammatory Response 
Paul Ehrlich discovered neutrophils in the 19th century1. He used hematological staining 
to distinguish different white blood cells based on their granules. Neutrophils were 
named so because of their ability to retain neutral dyes. He was also able to identify the 
lobulated nucleus that is characteristic of neutrophils. This led to the alternate 
nomenclature of neutrophils as ‘polymorphonuclear leukocytes’ by Elie Metchnikoff, a 
contemporary of Paul Ehrlich. Metchnikoff is also credited to be the first to 
demonstrate the phagocytic function of neutrophils in microbe digestion2.  
Neutrophils are integral to the development of the acute inflammatory response because 
they are the first cells to accumulate at the site of injury. They are also the most 
abundant leukocytes in the mouse blood accounting for 60% of the white blood cell 
count. Like other white blood cells, they are produced and undergo maturation in the 
bone marrow. Pluripotent hematopoietic stem cells (HSCs) give rise to all types of 
white blood cells or leukocytes namely granulocytes (neutrophils, basophils, and 
eosinophils) and agranulocytes (lymphocytes, monocytes, and macrophages) (Figure 
1.1). The earliest committed neutrophil progenitor cell is the myelocyte, which 
differentiates into a metamyelocyte, then a band neutrophil, and finally to a mature 
segmented neutrophil. 
 
Etiology and Trajectory of neutrophils 
The trajectory of neutrophils from the bone marrow to the site of inflammation involves 
three successive stages, each of which is precisely regulated: Release of neutrophils  
4
Figure 1.1 
Figure 1.1: Differentiation of Hematopoietic Stem Cells (HSCs) into different
types of white blood cells, including neutrophils
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from bone marrow into the blood circulation, Immigration from blood into the tissue 
site and Movement towards the site of inflammation. 
Release of neutrophils from bone marrow into the blood stream: Neutrophils are 
produced in hematopoietic cords interspersed within the venous sinuses of the bone 
marrow. HSCs become committed to the granulocytic lineage by their expression of 
transcription factors like Egr1 and STAT3, proteins like S100A8 and S100A9 and 
receptors like N-formyl methionyl-leucyl-phenylalanine and granulocyte-macrophage 
colony-stimulating factor (GM-CSF)3. Neutrophils spend most of their lifespan in the 
bone marrow; the average time lag between being neutrophil-lineage committed to 
subsequent release into blood stream is 12 days4,5.  
Neutrophil retention in the bone marrow and its exit into the blood stream is conversely 
regulated by the signaling through the CXC chemokine receptors (CXCR), CXCR2 and 
CXCR46-9 (Figure 1.2). The osteoblast-derived stromal-cell-derived factor (SDF)-1 acts 
through CXCR4 on neutrophils to retain neutrophils in the bone marrow. This is 
facilitated by the binding of the integrin, very late antigen (VLA)-4 on neutrophils to 
vascular cell adhesion molecule-1  (VCAM-1) expressed by bone marrow endothelial 
and stromal cells. On the other hand, the endothelial cell-derived CXCR2 ligands, KC 
(CXCL1) and macrophage inflammatory protein (MIP)-2 (CXCL2) mobilize 
neutrophils from the bone marrow. MIP-2 and KC counteract the effect of CXCR4 
signaling via heterologous internalization and desensitization of CXCR47. During the 
normal course of neutrophil maturation, they progressively down regulate the 
expression of CXCR4 and VLA-4, favoring their exit from the bone marrow. 
6Figure 1.2 
Figure 1.2: Regulation of neutrophil release from the bone marrow into blood  
CXCR4 and its ligand SDF-1 promote the retention of neutrophils in bone marrow, 
while CXCR2 and its ligands, MIP-2/KC stimulate neutrophil egress. G-CSF generated 
in bone marrow and in inflamed tissue site mobilizes neutrophils by modulating the 
ratio of CXCR2/CXCR4 ligands. 
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Granulocyte colony stimulating factor (G-CSF) is a cytokine regulating all aspects of 
granulocytogenesis, including commitment of HSCs to the myeloid lineage, expansion  
of neutrophil precursors, facilitating maturation of granulocytes, and their exit into 
blood4,5. G-CSF promotes the release of neutrophils into the bloodstream by 
downregulating the expression of SDF-1 by stromal cells and also the expression of 
CXCR4 by granulocytes6,10.  
Once in the blood steam, neutrophils have a very short life span (6-8 h). Neutrophils are 
destroyed in peripheral tissues like bone marrow, spleen, and liver by apoptosis and 
consequent phagocytosis by tissue macrophages and dendritic cells11,12. The production 
of neutrophils in the blood is regulated by the rate of apoptosis of neutrophils in these 
tissues though the IL-23 – IL-17A – G-CSF signaling axis13,14.  
During acute inflammation, cytokines like MIP-2, KC, and G-CSF get generated. These 
cytokines accelerate the release of neutrophils from the bone marrow into the blood 
(Figure 1.2). G-CSF as mentioned before, acts by downregulating the CXCR2-SDF-1 
retention mechanism. MIP-2 and KC attract neutrophils by generating concentration 
gradients across the sinus wall of bone marrow sinusoids15. 
Entry of neutrophils from blood into tissues: This process is also called extravasation of 
neutrophils (Figure 1.3). Tissue injury or infection is recognized by tissue-resident 
sentinel cells like macrophages leading to activation of intracellular signaling pathways. 
This leads to the production of mediators like cytokines (TNF-α, IL-1β), neutrophil 
chemoattractants (MIP-2, KC) and lipid mediators like prostaglandins. All these 
mediators promote the ‘adhesiveness’ of endothelium. They act by increasing the 
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expression of specific cell adhesion molecules on both the endothelium and neutrophils. 
G-CSF also increases transendothelial migration of neutrophils. The migration of these 
cells from the endothelium into the tissue occurs primarily in the postcapillary venules 
in following three steps16 (Figure 1.3): 
 Rolling: This event slows blood flow and causes neutrophils in the central 
column to marginate into the periphery. Here, they transiently stick to the endothelium 
surface. This process is called ‘rolling’. It is mediated by adhesion molecules called 
selectins, which are present on both neutrophils and the endothelium. Selectins mediate 
low-affinity binding, which accounts for the loose and transient interactions during 
rolling. Selectins have an extracellular domain, which binds to sugar moieties. Specific 
selectins are expressed on specific tissues, which allows for cognate interactions16. For 
e.g., E-selectin (or ELAM-1) is expressed by the endothelium; P-selectin (GMP140) is 
expressed by both endothelium and platelets and L-selectin is present on neutrophils. P- 
and E-selectins bind to glycoproteins on neutrophil surface. L-selectin binds to 
glycoproteins on endothelium. Selectins are expressed at low levels on endothelium but 
get upregulated during inflammation. 
Activation: Neutrophils, which are rolling on the endothelial cell surface are activated 
by chemokines that are bound to the endothelium by glycoaminoglycans17. Integrins are 
constitutively expressed on neutrophils. However, they require a conformational change 
to bind to endothelial adhesion molecules, which is facilitated by chemokine 
activation18. 
 Adhesion and Transmigration: Rolling is followed by the next stage of 
9
Figure 1.3 
 
 
Figure 1.3: Extravasation of Neutrophils  
Steps involved in the extravasation of neutrophils from blood into the inflamed tissue 
with the corresponding cell adhesion molecules expressed by neutrophils and the 
endothelium. 
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neutrophil trafficking in which they firmly adhere to the endothelial surface and pass 
via the intracellular junctions through the basement membrane into the interstitial 
space. This process of transmigration is termed diapedesis. It is facilitated by 
chemokine-mediated activation of neutrophils. It is mediated by the high-affinity 
interactions involving adhesion molecules of the immunoglobulin (expressed on 
endothelium) and integrin (expressed on neutrophils) families. Examples of endothelial 
adhesion molecules are ICAM-1 (intracellular adhesion molecule 1) and VCAM-1 
(vascular cell adhesion molecule 1). ICAM-1 binds to integrins LFA-1 (CD11a/CD18) 
and Mac-1 (CD11b/CD18) and VCAM-1 binds to VLA-4 on neutrophils19. Expression 
of endothelial adhesion molecules is enhanced by inflammatory stimuli20. 
Transmigration occurs mainly in the venules of the systemic vasculature and also in the 
capillaries of lungs. To cross the basement membrane, neutrophils secrete collagenase 
to degrade the membrane. 
Movement towards the site of inflammation: Once inside the tissue, neutrophils must 
make their way towards the site of injury. This is accomplished by spatial and temporal 
cascades of chemoattractants, which are generated when tissue-resident cells sense the 
infection or injury. In the mouse models of focal skin injury, two different sets of 
chemoattractants guide immigrating neutrophils to the site of injury21. The movement 
of neutrophils to about 150µm around the lesion is accomplished by gradients of MIP-2 
and KC. Beyond this point, neutrophils move towards a gradient of mitochondrial 
formyl-peptides released by necrotic cells, by means of their expression of the formyl 
peptide receptor (FPR)1. The ligation of FPR1 or other chemokine receptors leads to 
11
the activation of the MAPK/ERK pathway. Downstream molecules of the MAPK/ERK 
pathway promote degranulation and oxidative burst in the activated neutrophils. 
Neutrophils also express pattern recognition receptors like TLRs (except TLR3), 
dectin-1, RIG-I, MDA5, and NOD1 constitutively22-25. The ligation of these receptors 
by microbial or cell-derived ligands in the tissue site also promotes oxidative burst. 
Furthermore, G-CSF has a pivotal role in promoting neutrophil degranulation by 
simulating mobilization of secretory vesicles26.  
 
Neutrophil Phagocytosis and Degranulation 
The ultimate function of neutrophils is eliminating the noxious agent. This is achieved 
though the process of phagocytosis and consequent release of their granular contents. 
Neutrophils have numerous specialized cytoplasmic granules containing acid 
hydrolases and antimicrobial peptides. There are three major groups of granules 
containing different molecules and produced at different stages of maturation. Primary 
granules are developed first and contain myeloperoxidase; secondary granules mature 
next and contain lactoferrin but no myeloperoxidase. The tertiary granules, which 
develop in later stages contain gelatinase and surface receptors27.  
Phagocytosis of the microbe or necrotic cell is accompanied by release of granular 
mediators. In general, these mediators can function in either oxygen-dependent or 
oxygen-independent mechanisms28. The oxygen-dependent mechanism involves the 
generation of reactive oxygen species (ROS) in a process called ‘respiratory burst’. 
Following activation, the multimeric NADPH oxidase enzyme complex is activated, 
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which oxidizes NADPH (nicotinamide adenine dinucleotide phosphate). The activation 
of the oxidative machinery is a multi-step process often requiring a ‘priming’ step. For 
example, neutrophil response to formyl peptides requires priming by LPS. LPS is 
required for the assembly of the NADPH oxidase complex while formyl peptides 
stimulate its activation.  
The oxidation of NADPH generates superoxide ion. Superoxide gets converted by 
spontaneous dismutation into hydrogen peroxide (H2O2). Neutrophils further convert 
H2O2 into HOCl (hypochlorous radical) by the action of the enzyme myeloperoxidase 
(MPO). Other reactive oxygen intermediates like singlet oxygen, hydroxyl radical, and 
ozone are also generated in phagocytes. These are powerful antimicrobial agents, which 
kill microbes by halogenation or by protein and lipid peroxidation. The dead microbes 
are further degraded by the action of lysosomal acid hydrolases.  
            Besides ROS, other proteins present in leukocyte granules are bactericidal too. These 
molecules account for the oxygen-independent killing mechanisms. They include the 
bactericidal permeability increasing protein (BPI), lysozyme, lactoferrin, and defensins.  
An alternate method by which neutrophils kill microbes is the formation of neutrophil 
extracellular traps (NETs)29. Upon activation by an inflammatory stimulus like TLR 
ligation, neutrophils die, rupturing the cell membrane. This process releases 
nucleosomes from unfolded chromatin. NETs comprise of threads of chromatin, which 
form a web-like structure. Other proteins from the neutrophilic granules may be 
attached to this structure. NETs can trap gram-positive and gram-negative bacteria and 
fungi and facilitate their killing by other anti-microbial effectors. 
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Survival of neutrophils in tissues 
In peripheral tissues, neutrophils have a short half-life of about eleven hours, rapidly 
undergoing apoptosis. Signals like TH17 cell-derived cytokines (such as IL-17, CXC-
chemokine ligand 8 (CXCL8; also known as IL-8), interferon-γ (IFNγ), tumour 
necrosis factor (TNF) and granulocyte–macrophage colony-stimulating factor (GM-
CSF)) greatly influence not only activation and extravasation of neutrophils but also 
their survival in tissues30,31. TNF is interesting in this regard that lower concentrations 
promote neutrophil longevity while higher concentrations promote apoptosis32.  
 
Antigenic markers of neutrophil development 
During their development in bone marrow and release into blood stream, neutrophils 
are classified into myeloblasts, promyelocytes, myelocytes, metamyelocytes, bands, 
and segmented neutrophils based on their morphological characteristics. In normal 
conditions, mature or segmented neutrophils are released into the blood. Segmented 
neutrophils are named so because of their characteristic nuclei, which appear 
segmented into lobes of condensed chromatin connected by filaments. During 
inflammation, however, both mature and immature neutrophils may be released into the 
circulation.  
The most widely used antigenic marker of neutrophils is Ly6G33. These are small 
glycosyl-phosphatidylinositol (GPI)-linked proteins on the surface of mouse 
neutrophils. The expression of Ly6G is not constant but is low on immature cells and 
increases as granulocytes mature. Hence, a number of different markers are used to 
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reliably identify neutrophils34. The expression profiles of some of these antigenic 
epitopes based on different phases of maturation of neutrophils has been summarized in 
Table 1.1. Fully mature neutrophils can be distinguished by their high expression of 
CD10, CD11b, CD16, and CD45RO35-40. On the other hand, they express low to none 
CD45RA and CD64, which are preferentially expressed on the immature forms of 
granulocytes40-43.  
 
Effect of G-CSF and GM-CSF on neutrophil production, maturation, and function 
Both granulocyte colony stimulating factor (G-CSF) and granulocyte-macrophage 
colony-stimulating factor (GM-CSF) have been approved for treatment for neutropenia 
in human patients44-46. Though both these hematopoietic growth factors influence 
neutrophil production and phenotype, they are differences in their specificity of action 
on developing and mature neutrophils, and their effects on neutrophil kinetics. A major 
difference is in the expression of their cognate receptors and hence their specificity of 
action. G-CSF receptor is expressed almost exclusively on neutrophil progenitors and 
mature neutrophils47. On the other hand, GM-CSF receptors are expressed on 
neutrophils, monocytes, macrophages, and eosinophils as also non-hematopoietic cell 
lineage like endothelial cells, myeloid leukemia cells, and a variety of tumor cell 
lines48. G-CSF appears to be more critical than GM-CSF for the development of 
neutrophils. As mentioned before, G-CSF leads to the differentiation of committed stem 
cells into granulocytes and also mobilization of mature cells into the circulation47,49,50. 
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Table 1.1  Proliferating precursor cells Non-­‐dividing cells(Immature cell pool) (Mature cell pool)
StagesAntigen Blast Promyelo Myelo Metamyelo Band SegCD10 -­‐ -­‐ -­‐ -­‐ -­‐ ++CD11b -­‐ -­‐ -­‐ ++ ++ +CD11c -­‐ -­‐ ++ ++ ++ ++CD15 + +++ +++ +++ +++ ++CD16 -­‐ -­‐ -­‐ + ++ +++CD33 +++ +++ ++ + + +CD44RA + + -­‐ -­‐ -­‐ -­‐CD44RO -­‐ -­‐ + + ++ +++CD62L ++ ++ ++ ++ ++ ++CD64 + + ++ ++ -­‐ -­‐
Table 1.1: Expression of antigenic surface markers based on the stage of 
maturation of neutrophils  
Blast, Myeloblast; Promyelo, promyelocyte; Myelo, myelocyte; Metamyelo, 
metamyelocyte; Seg, segmented neutrophil. +++, strong expression; ++, moderate 
expression; +, weak expression; -, no expression. 
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Mice knockout for G-CSF are chronically neutropenic51. GM-CSF broadly influences 
hematopoiesis, stimulating differentiation of committed stem cells into neutrophils, 
eosinophils, and monocytes50,52-54. GM-CSF seems to be dispensable to neutrophil 
development, since GM-CSF knockout mice are not neutropenic55.  
Both G-CSF and GM-CSF increase peripheral neutrophil numbers by increasing the 
rate of progenitor cell divisions, reducing maturation time and increasing half-life of 
mature circulating cells, though G-CSF is more potent than GM-CSF in this 
regard5,56,57. 
Both G-CSF and GM-CSF are effective in enhancing the phagocytic potential of 
neutrophils58-61. They promote antibody-dependent cellular cytotoxicity, adherence, and 
microbial killing59-66. They also serve as chemoattractants and promote transendothelial 
migration of neutrophils67-69. They increase the expression of cell adhesion molecules 
by neutrophils70. They stimulate respiratory burst; GM-CSF is more effective than G-
CSF in this function71. They enhance the survival of neutrophils in tissue13,14,72. 
 
1.1.3. Signaling pathway leading to Neutrophil Migration 
Neutrophils are the effector cells of the acute inflammatory response, which is a 
signaling cascade that is initiated when the body encounters a foreign or an altered self 
molecule(s). This response comprises of four functional categories of molecules or 
cells. These are inducers, sensors, mediators, and effectors73. Some examples of the 
signaling cascades elicited by inflammatory particles are given in Table 1.2. They will 
be described below in detail.  
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Table 1.2 
 
 
Table 1.2: Lineup of the acute inflammatory response with specific examples 
The specific type of “inducer” determines the downstream signaling candidates that get 
activated73.  
 
 
 
 
 
 
 
 
 
 
 
 
Inducer Sensor Mediator Effector
Meso-­‐diaminopimelic acid(Peptidoglycan from Gram-­‐negative bacteria) NOD1 TNFα, IL-­‐6 Neutrophils, hepatocytes, splenocytesHouse dust mite allergen TLR4 Histamine Endothelial cells, smooth muscle cellsCholesterol crystals NALP3 IL-­‐1β Endothelial cells, smooth muscle cells,macrophages, neutrophilsCollagen (Extracellular matrix) RAGE ROS, IL-­‐1β Endothelial cells, smooth muscle cells,macrophages
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“The Inducers”  
These molecules are agents that initiate an acute inflammatory response. They can be 
broadly divided into following groups and sub-groups: 
1) Exogenous agents 
i. Microbial 
a. Pathogen-associated molecular patterns (PAMPs) 
b. Virulence factors 
ii. Non-microbial 
2) Endogenous agents 
i. Cell injury 
 
Pathogen-associated molecular patterns (PAMPs):  
These are small molecular motifs that are conserved within a class of microbes and are 
distinct from host-derived molecules. They are recognized by specific receptors 
expressed by the host immune system called the pattern recognition receptors (PRRs)74. 
The major classes of PRRs and their signaling modules will be discussed later. 
Common examples of PAMPs are lipopolysaccharide (LPS), which is a component of 
the bacterial cell wall and zymosan, which is a component of the yeast cell wall. 
Contrary to what the name suggests, PAMPs are not solely expressed by pathogens. 
Commensal bacteria that are present on the host tissue surfaces also display PAMPs.  
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Virulence factors:  
The other types of exogenous microbial inflammatory agents are virulence factors. 
There appears to be an overlap between the definitions of PAMPs and virulence factors 
as some reviews also cite LPS as a virulence factor75. However, unlike PAMPs, most 
virulence factors are not detected by specific PRRs on host tissues. They perturb the 
host tissue homeostasis leading to the generation of a downstream effector molecule 
that is detected by the cognate host sensor. Examples of such virulence factors are the 
pore-forming exotoxins generated by Gram-positive bacteria76-78. There is an efflux of 
potassium ions through the cell as a result of the channel-forming toxins. Potassium 
efflux is sensed by the NALP3 (NACHT-, leucine-rich-repeat-and-pyrin-domain 
containing protein) inflammasome, which activates the inflammatory pathway79. The 
inflammasome pathway has been described later. Alternatively, toxins released by 
pathogens cause cell death. The secondary effect of endogenous molecules released on 
account of cell death stimulates inflammation.  
Exogenous non-microbial agents:  
Examples of such noxious agents include crystals, allergens and other toxic 
components. Inhalation of silica crystals or asbestos particles causes inflammation in 
the alveolar space in a NALP3 inflammasome-dependent way80. Other examples of 
exogenous non-microbial particles are certain allergens (though some allergens may be 
microbe-derived). Allergens may mimic certain host signaling proteins. One such 
example is the house dust mite allergen Der p 2, which mimics the Toll-like receptor 4 
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(TLR4) signaling co-factor leading to activation of the TLR4-dependent pro-
inflammatory pathway81.  
Cell injury-derived agents:  
Non-physiological cell death, tissue damage or stress is inflammatory82. Like microbes, 
which display specific signature molecules, there are certain cell-derived molecules, 
which stimulate inflammation83. These are called damage associated molecular patterns 
(DAMPs). In normal cells, these molecules are encased in the cellular membrane or 
sub-cellular compartments and hence are ‘hidden’ from the host immune system. 
During necrotic cell death, however, such molecules get released into the 
environmental milieu. Examples of molecules, which may be putative DAMPs are 
ATP84,85, HMGB1 (high-mobility group box 1 protein)86, heat shock proteins87-90, 
double stranded DNA91-93, thioredoxin94, and galectins95. In other cases, certain 
molecules are released upon necrotic cell death, which act upon components of the 
extracellular matrix to generate pro-inflammatory products. For example, various 
hydrolases and proteases released from the cell cleave collagen96, heparin sulfate97, and 
hyaluronic acid98,99 to generate pro-inflammatory molecules.  
Another class of endogenous inflammatory agents is associated with chronic 
inflammation during certain diseases. These include crystals like monosodium urate 
(MSU)100, cholesterol101, and also advanced glycation end products (AGEs)102.  
 
 
 
21
 “The Sensors” 
As mentioned earlier, certain conserved motifs on microbes and other foreign signals 
are recognized by “sensors” expressed by host cells, also called pattern recognition 
receptors (PRRs) (Figure 1.4)74. These set of receptors are germ-line encoded and are 
either present in body fluids, on cell membranes or in the cytoplasm of tissue-resident 
cells like macrophages, mast cells, fibroblasts and dendritic cells. Activated PRRs 
oligomerize and assemble into large macromolecular complexes. The latter induce 
either several extracellular activation cascades like the complement pathways or 
intracellular signaling pathways. The overall effect of activation of these pathways is 
the production of chemokines and cytokines, type I interferons, (IFNs), antimicrobial 
proteins, regulatory proteins of PRR signaling and other uncharacterized proteins and 
promotion of phagocytosis. Chemokines and cytokines cause vascular changes and 
promote chemotaxis of leukocytes to the site of infection/injury. PRRs may be present 
in body fluids (e.g., components of the complement pathway), on cell membrane or 
other sub-cellular membranes (e.g., TLRs and C-type lectins) or in cytoplasm (e.g., 
nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs)) 
 
Some of the major signaling pathways are described in detail below: 
Toll-Like Receptor (TLR) Family:  
TLRs are one of the most studied inflammatory signaling pathways. They are 
characterized by the presence of the extracellular/luminal domain that has leucine rich 
repeats (LRRs). LRRs function in ligand recognition. The cytoplasmic tail has the  
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Figure 1.4 
 
 
Figure 1.4: Signaling Cascades induced by Pattern Recognition Receptor Ligation 
Generation of NF-κB, MAPK and IRF3 by converging intracellular pathways initiated 
by cell membrane and cytosolic “sensors”. 
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Toll/IL-1R homology (TIR) domain, which functions in downstream signal 
propagation. The TLRs are examples of Type I integral membrane glycoproteins. They 
function as homodimers or heterodimers.There are 12 known TLRs in mammals103. 
TLRs respond to diverse ligands associated with pathogens like bacteria, viruses, fungi 
and parasites as well as certain endogenous ligands.  
Distribution of TLRs in tissues: Most human tissues are known to express at least one 
type of TLR, but innate immune cells exhibit high expression of most TLRs. The 
distribution of various TLRs differs between innate immune cells104. Macrophages or 
monocytes express all TLRs except TLR3105. The expression of TLRs on dendritic cells 
depends upon the particular dendritic cell subset. Myeloid dendritic cells express 
(MDCs) express TLR1, 2, 4, 5, and 8, while plasmacytoid dendritic cells (PDCs) 
express TLR 7 and 9106-108. Another type of tissue-resident cells, mast cells express 
TLR2, 4, 6, and 8109. 
The expression of TLRs on the epithelial cells lining mucosal surfaces is regulated in 
such a way that it serves the dual purpose of defense against mucosal pathogens but 
tolerance towards mucosa-associated commensal bacteria104. One of the means to 
accomplish these dual functions is by the specific localization of TLRs on the 
basolateral surface of epithelial cells and not the apical surface, which is continuously 
exposed to normal microbiota. For e.g., TLR5 is expressed only on the basolateral 
surface110. Another method for achieving tolerance to commensals is by the low 
expression of TLR4 on the intestinal epithelium111,112.  
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TLR-mediated signaling pathways: Different TLRs recruit different combinations of 
adaptor molecules, which determine the downstream signaling pathways activated by 
each TLR.  All these adaptor proteins associate with their partner TLRs via TIR 
domains. TLR ligation leads to the activation of two major signaling pathways. All 
TLRs activate the transcription factor, nuclear factor-κB (NF-κB) and the Mitogen-
activated protein kinases (MAPKs): p38 and c-Jun Kinase (JNK)113. In addition, TLR3 
and TLR4 activate NF-κB as well as the transcription factor Interferon regulatory 
factor-3 (IRF3); the latter leads to the activation of Type I interferons114,115. 
All TLRs signal via MyD88 except TLR3. TLR3 and TLR4 can also signal in a 
MyD88-independent way via IFN-β (TRIF), also known as TICAM-1114.  
 
RIG-I like receptors (RLRs):  
The RLRs are cytosolic PRRs, which detect non-self RNA in the cytoplasm. This 
family of receptors includes RIG-I, MDA5 and LGP2116. RLRs are characterized by a 
central DExD/H-box helicase domain and a RNA-binding carboxy-terminal regulatory 
domain (CTD). RIG-I and MDA5 have an amino-terminal caspase activation and 
recruitment domain (CARDs), which mediate downstream signaling117. RIG-I and 
MDA5 detect and respond to distinct species of viruses118. LGP2 positively regulates 
RIG-I and MDA5 signaling119. RIG-I detects 5’ triphosphate of double stranded RNA 
derived either from virus or RNA intermediates generated from cytosolic microbial 
DNA by the action of RNA polymerase III120. RIG-1 binds to its CARD-domain 
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containing adaptor partner called MAVS121. Downstream signaling mediated by 
ligation of MAVS leads to the activation of IRF3, IRF7, and NF-κB. 
 
NOD-like receptors (NLRs):  
As the RLRs, NLRs are also present in the cytoplasm. They are characterized by the 
presence of LRRs at the carboxy termini, which mediate ligand sensing as well as 
autoregulation122-126. A centrally located NACHT domain mediates self-oligomerization 
and activation122,127. The amino-terminal effector domain, which may be either CARD, 
pyrin (PYD) or baculovirus IAP repeat (BIR) domain facilitates interaction with 
adaptor proteins for downstream signaling128-131. Based on the nature of the effector 
domain, NLRs can be divided into subfamilies: NODs, NLRPs, CIITA, IPAF, and 
NAIPs. NODs, IPAF, and CIITA have the CARD effector domains and NALPs have 
the PYD effector domains while NAIPs have the BIR domains132. 
 NOD1 and NOD2: These are cytoplasmic sensors of microbial cell wall 
components. NOD1 detects a specific muropeptide present in gram-negative bacteria. 
NOD2 is a general sensor of peptidoglycan and hence can respond to most bacteria. 
Ligand recognition by either NOD1 or NOD2 leads to the activation of RICK (also 
called RIP2). Downstream signaling by RICK results in NF-κB activation129,133-135.  
 Inflammasomes: Inflammasomes are multimeric complexes, which recognize 
diverse microbial and sterile stimuli to activate a pathway that leads to the processing 
of cytokines like IL-1β and IL-18 to yield mature proteins. Inflammasomes, which 
belong to the NLR family of receptors contain the NACHT domain, LRRs and either or 
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both of the CARD/PYD domain136. Examples of these inflammasomes include NALP1, 
NALP2, NALP3, NALP6, NLRC4, and NALP12. Other inflammasomes such as AIM2 
and IFI16 have the PYD domain and the HIN200 domain, the latter mediates ligand 
binding.  
Production of functionally active and secreted- IL-β requires a cross talk between TLRs 
and NALPs137. TLR signaling leads to increased transcription of immature pro- IL-β. 
The cleavage, activation, and subsequent secretion of mature IL-1β require the action of 
the cysteine protease caspase-1. Caspase-1 itself is synthesized as a non-functional 
zymogen called pro-caspase-1. Pro-caspase-1 is cleaved by the assembly of the 
multimeric NALP inflammasome. Inflammasome proteins bind directly to pro-caspase-
1 by the CARD domain or indirectly through the PYD domain, via a protein ASC, 
which contains both ASC and PYD domain.  
Ligands activating the NALP3 inflammasome have been extensively researched and 
include a variety of endogenous, environmental, and microbial stimuli. Some of the 
examples of NALP3 activators are microbial toxins like maitotoxin and nigericin79, 
environmental stimuli like silica and asbestos80, and endogenous stimuli like 
monosodium crystals138. There have been efforts to understand if all these diverse 
molecules have a unifying underlying cause of inflammasome activation. Production of 
ROS80,139,140, lysosomal rupture resulting from ingestion of crystalline particles141,142, 
and formation of the ATP-dependent pannexin-1 membrane pore143 seem to be events 
occurring downstream of some of the ligands, purported to cause inflammasome 
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assembly.   
The AIM2144 and NALP1145 inflammasome have more specific ligands, double-
stranded DNA and muramyl dipeptide respectively.  
 
C-Type Lectin Receptors (CLRs):  
Calcium-dependent (C-type) lectins are a group of proteins, which have the high-
affinity carbohydrate binding domain146. There are 17 known groups of CLRs in 
vertebrates. They perform diverse functions like capture and uptake of endogenous 
ligands, microbes, and PAMPs. Examples are collectins, which are serum proteins, 
which bind pathogens and activate complement. CLRs take up particles either by 
endocytosis or phagocytosis.  
Dectin-1 is the only CLR, which has been conclusively shown to activate expression of 
innate response genes147. Dectin-1 recognizes zymosan, a yeast cell wall particle. 
Dectin-1 can induce phagocytosis and cytokine production. Dectin-1 has an 
immunoreceptor tyrosine-based activation (ITAM)-like motif, which mediates 
intracellular signaling. Responses initiated by Dectin-1 ligation can be Syk kinase-
dependent or independent147,148. Dectin-1 has been shown to promote the production of 
inflammatory cytokines by activating NF-κB. 
 
“The Mediators” 
“Inducers” of inflammation act on cell-resident “sensors” to trigger the production of 
chemical “mediators”. The vascular and cellular events that lead to the inflammatory 
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response are a result of these mediators, which are either released from cells or are 
present in plasma. Plasma-derived factors need to be cleaved by proteases before they 
are functionally active. Examples of plasma-derived mediators are factors associated 
with the clotting system, the complement system and the kinins. Cell-derived factors 
are sequestered in granules and released or generated de novo after stimulation. 
Examples of cell-derived mediators are vasoactive amines (e.g., histamine and 
serotonin) and products of phospholipids (e.g., platelet-activating factor) and 
arachidonic acid metabolism (e.g., prostaglandins and leukotrienes), cytokines, nitric 
oxide and oxygen-derived free radicals and lysosomal constituents. Some of the 
functions performed by these inflammatory mediators are vasoconstriction and 
bronchoconstriction, arteriolar vasodilation and increased vascular permeability, 
increased leukocyte adhesion, chemotaxis and leukocyte activation. 
 
Cytokines and Chemokines: 
As described in previous sections, signaling pathways downstream of PRR ligation 
(except the NALPs, IPAF and NAIPs) lead to the activation of transcription factors NF-
κB, AP-1, IRF5, and IRF3 (Figure 1.2). These transcription factors regulate 
inflammation is several ways, by influencing the transcription of cytokines, 
chemokines, growth factors, acute - phase proteins, immunoreceptors and adhesion 
molecules. Cytokines whose expression is regulated by NF-κB, AP-1, and IRF5 include 
Tumor Necrosis Factor-α (TNF-α), Interleukin-1 (IL-1), IL-1, IL-8, Interferon-β (IFN-
β), RANTES, Macrophage chemotactic protein-1 (MCP-1) and Granulocyte colony-
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stimulating factor (G-CSF)149. IRF3, in conjunction with NF-κB and JNK stimulates 
the expression of Type I interferons, namely, Interferon-α (IFN-α) and Interferon-β 
(IFN-β)150. While signaling through most PRRs results into increased transcription of 
cytokines including IL-1, the activation of the NALPs, IPAF and NAIP is important for 
the post-translational processing of IL-1β and IL-18 to yield mature cytokines136.  
Cytokines like TNF, IL-1, MIP-2, KC, IL-6 play a crucial role in orchestrating the 
inflammatory response by determining the types of cells that infiltrate into the tissue, 
their state of activation, and the systemic responses to inflammation. IL-1 is particularly 
important for the cell-death induced inflammatory response. This function will be 
further explored in the chapter 3 of this thesis.  
 
 “The Effectors” 
“Mediators” released during inflammation modulate the functional states of tissues and 
cells, giving rise to the pathology of the acute inflammatory response. As described 
before, neutrophils are the key effectors of the acute inflammatory response. Besides 
neutrophils, there are other tissue-resident and recruited cells that play important roles 
in this response. 
Mast cells: Mast cells are found in almost all tissues151. In those tissues, which have 
fewer numbers of mast cells, their number increases during inflammation. The 
immediate massive degranulation of mast cells to release inflammatory meditors is 
associated with IgE-mediated type I hypersensitivity reactions. Apart from the FcεRI, 
mast cells possess other innate immune receptors like TLRs, complement receptors and 
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receptors for inflammatory peptides and hormones. Immune activation of mast cells 
results into an immediate release of the contents of their cytoplasmic granules. Stored 
in the cytoplasmic granules are inflammatory mediators like histamine, proteoglycans, 
and other specific proteases as also cytokines like TNF. Also other chemokines and 
cytokines and some arachidonic acid metabolites are synthesized de novo and released 
later.  
Platelets: Platelets are produced in the bone marrow from where they are released into 
the circulation152. They lack nucleus, hence they appear as irregularly shaped cell 
fragments. Platelets get activated when they come in contact with fibrillar collagen, 
which is exposed at the injured endothelium. Also, activation of the coagulation system, 
which generates thrombin can activate platelets. Once activated, platelets release 
serotonin and the arachidonic acid metabolite (TxA2), which cause increased vascular 
permeability and smooth muscle constriction.  
Endothelial cells: As described before, endothelium plays an important role in 
inflammation by regulating the degree of tissue perfusion152. A delicate balance 
between the production of vasoconstrictors and vasodilators controls the level of 
vascular permeability. Vasoactive mediators synthesized by endothelial cells in 
inflammatory conditions include PGI2, endothelium-derived relaxing factor (EDRF), 
and endothelin. Besides, endothelial cells control vascular permeability by regulating 
fibrinolysis.  
Monocytes/ Macrophages: Monocytes are generated in the bone marrow152. Under 
physiologic conditions, circulating monocytes have a half-life of about a day. Similar to 
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chemotactic emigration of neutrophils into the tissue, they infiltrate the inflamed site 
within 24-48 hours of injury. However, when they enter the tissue, they transform into 
larger cells specialized in phagocytosis called macrophages. Macrophages can be found 
in many tissues, where they have specific names like kupffer cells (liver), sinus and 
lymph nodes (spleen and lymph nodes), microglia (central nervous system), and 
alveolar macrophages (lungs).  
Macrophages have been shown to be the primary cellular sensors for necrotic cell deth-
induced damage153. Macrophages can also get activated by cytokines IFN-γ and other 
inflammatory stimuli like LPS. Once activated, macrophages increase in size, express 
more lysosomal enzymes and become better phagocytes. They also secrete 
inflammatory mediators like acid and neutral proteases, and plasminogen activator. 
Though most of the complement components and coagulation factors are synthesized in 
the liver, macrophages are also able to secrete them locally. Besides, they make ROS, 
NO, eicosanoids, and cytokines. Upon clearance of the inflammatory agent, 
macrophages die and are cleared via the lymphatics154. 
 
1.1.4. Inflammation: A double-edged Sword 
Neutrophils, once recruited to the site of infection, are powerful phagocytes that kill 
microbes and help clear the infection. The importance of neutrophil function is evident 
in individuals who have a defect in neutrophil chemotaxis or phagocytic 
functions155,156. These individuals are more prone to bacterial infections. In the case of 
sterile inflammation, effector molecules released from neutrophils and other recruited 
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cells help eliminate and clear the cell debris and aid in resolution of the wound. 
However, in some instances, the neutrophil response can be counterproductive to the 
host. Microbicidal molecules released from activated neutrophils can cause damage to 
bystander healthy tissue157. The consequent cell injury and death can aggravate the 
inflammatory condition, exacerbating the damage. This situation is particularly relevant 
when the inciting stimuli are sterile particles like crystals. The accumulation of crystals 
may not be as harmful to the host as the collateral damage caused by recruited 
neutrophils. Hence it is essential to study the factors controlling neutrophil migration 
and activation.  
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1.2. OVERVIEW OF COMMENSAL MICROBIOTA 
 
1.2.1. Mutualism between Eukaryotes and Bacteria 
The term ‘symbiosis’ was coined by the German botanist Heinrich Anton de Bary in 
1829 to refer to a close physical association between organisms that extends for a 
significant period of their life cycles. Based on the outcome of this interaction, 
symbiotic relationships may further be classified as mutualism, commensalism, 
amensalism, and parasitism. When both the interacting partners benefit in terms of their 
growth, survival or procreation, the association is termed as ‘mutualism’, whereas, if 
only one partner benefits with no effect on the other, it is known as ‘commensalism’. 
Amensalism and parasitism are interactions, which are detrimental to one partner while 
being advantageous or neutral to the other158. All these types of associations have been 
powerful forces in determining a species’ fitness during natural selection. 
Amongst the most widespread of these symbiotic associations are the ones involving 
microorganisms and warm-blooded animals like humans. In fact, the extent of 
colonization by bacteria in humans is such that bacterial mass accounts for 10% of the 
dry body weight in humans. The large intestine is the organ with the largest numbers 
and diversity of microbiota, though bacterial colonization occurs at other mucosal 
surfaces and skin too. The intestinal microbiota aids in crucial functions of metabolism 
and immunity while deriving a hospitable ecological niche in the gut. A detailed 
account of the distribution and the diverse functions performed by microbiota with 
emphasis on their role in immunity will be done in the next two sections.  
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1.2.2. The human microbiome 
The human microbiome (or the human microbiota) is a collective term that refers to all 
the microorganisms that colonize the different anatomical sites and surfaces of the 
human body. They are also called ‘commensal microflora’, though this a misnomer on 
two counts, firstly this is an association which generally benefits both partners and 
hence is mutualistic rather than commensal and secondly, the term ‘flora’ specifically 
denotes plants. There are over 500 species of microorganisms that include bacteria, 
fungi and archae. They reside on the skin, conjunctiva, oral cavity, respiratory tract, 
gastrointestinal tract and urogenital tract. In utero, the fetus is sterile, but microbial 
colonization initiates during and within 48 hours of birth. Interestingly, the colonization 
pattern varies with the type of delivery (caesarean vs. natural)159, kind of feeding (bottle 
vs. breast feeding)160 and as adults, individual’s genetic makeup, sex, age, hygiene etc. 
But in general, the microbiota at a specific anatomical site is fairly constant within the 
species. 
Because of the sheer number and diversity of bacterial burden in the intestine tract, gut 
flora is the most widely studied human microbiota. There are about 100 trillion bacteria 
over a stretch of 400m2 of the intestinal tract161. The bacterial density is not uniform 
along with intestinal tract, with as few as 104/g of luminal contents in the stomach to 
1011- 1014/g in the large intestine. The identification of intestinal bacteria was a 
challenge because most of them do not grow in routine culture media. But 16S rRNA 
sequencing and molecular fingerprinting methods have enabled the identification of 
more than 40,000 species in the gastrointestinal tract.  
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The composition of bacterial species varies at different sites of the intestinal tract. In 
the stomach and the proximal small intestine, there is low bacterial colonization 
because of the acidic stomach juices, bile, and alkaline pancreatic juices. The acid-
resistant lactobacilli, enterococci, oral streptococci, are the most pre-dominant species 
in the stomach. Most Americans are also colonized by the pathogenic Helicobacter 
pylori, which has been linked to gastric cancer. The proximal small intestine mostly 
includes lactobacilli and Enterococcus faecalis, oral streptococci, and other gram-
positive aerobic or facultative anaerobes. The distal small intestine (ileum) represents a 
transition zone between the proximal small intestine, which is dominated by aerobic 
species and the large intestine, which primarily houses anaerobes162. There are about 
108/g of bacteria, which include gram-negative microbes like E. coli and Bacteroides, 
apart from lactobacilli and enterococci. 
The number and variety of enteric flora drastically increases in the large intestine 
reaching up to 1014 cells/g (colon). The microbial composition of colonic contents 
matches with that of the feces. As mentioned previously, the colon comprises mainly of 
anaerobes such as Bacteroides, Porphyromonas, Bifidobacterium, Lactobacillus, and 
Clostridium. Of these, Bacteroides constitute about 30% of the total gut flora and thus 
are key anaerobes in health and disease. Intestinal Bacteroides consist primarily four 
species, B. thetaiotaomicron, B. vulgatus, B. distasonis and B. fragilis. There are 100-
1000 fold more anaerobes to aerobes in the colon163. The composition of the colon 
changes after birth. At birth, the microbiota is predominated by facultative aerobes like 
streptococcus and Escherichia coli, but after weaning there is a shift towards obligate 
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anerobes, like Bacteroides sp163. Specific functions in establishing local and systemic 
immunity has been attributed to some of these bacterial species. These functions are 
discussed in the next section. 
 
1.2.3. Functions of Gut Flora 
Several recent studies have implicated a role for gut flora in diverse functions relating 
to metabolism, nutrition, tissue maintenance and immunity. These hitherto unknown 
functions attributed to the gut flora, along with the sheer enormity of their numbers, 
have prompted researchers to call it ‘a forgotten organ’164. In fact, the term ‘human 
microbiome’ was proposed by Dr. Joshua Lederberg, a Nobel Laureate in 1958, who 
had the foresight to realize that, the comprehensive knowledge of human genetics and 
physiology is a composite of both human and microbial genetics165. The importance of 
gut flora in maintaining healthy metabolism was first discovered in “germ-free” rats, 
which were totally devoid of commensal flora including gut flora166.  Since then, the 
use of germ-free animals has been pivotal in elucidating the functions of gut flora in 
physiology and disease. The functions of microbiota, specifically gut flora, can be 
broadly divided into two categories, in nutrition and in immunology. The nutritive 
benefits of gut flora include carbohydrate fermentation and absorption, lipid storage 
and secretion of vitamins and amino acids and absorption of minerals. The functions of 
gut flora in the host immunity are discussed below. 
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Immunological functions of gut flora:  
The intestinal epithelium, which is a host for an enormous microbial community, also 
houses the largest mass of lymphoid tissue in the human body.  The bacterial colony is 
separated from the internal immune tissue by only a single layer of epithelial cells167. 
The most obvious immunological function of the gut flora to the host is forming a 
natural defense barrier at this site, preventing access to pathogens. Besides, the 
enormity and diversity of enteric bacteria ensures that invading pathogens face 
competition in terms of availability of nutrients and receptors for attachment. This is 
supported by studies in germ free-mice, which show that these mice are more 
susceptible to infection by enteric pathogens like Shigella flexneri, Listeria 
monocytogenes, Clostridium difficile, and Salmonella enterica168-170. As would be 
expected, germ-free mice developed some resistance to these infections, when 
colonized by specific commensal bacteria. 
What was initially assumed to be a mere “competitive role” in immunity against 
pathogens has now broadened to reveal a more extensive role for commensal 
microbiota. The past decade has been particularly exciting in the field of gut immunity. 
More surprising is the fact that gut flora not only influences the local immunity in the 
gut lymphoid tissue, but also has profound effects on systemic immunity. Efforts have 
been made in understanding the molecular signaling pathways by which commensal 
flora influences the various arms of immunity. Studies reveal that commensal bacteria 
and pathogens use the same signaling machinery in the host cells. This has led to the 
conundrum, how does host immunity discriminate between ‘good’ commensal flora and 
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‘harmful’ infectious bacteria? What prevents commensal flora from penetrating host 
tissue and leading to inflammation and sepsis? What are the mechanisms by which the 
host has developed tolerance to these microbial antigens? The functions of microbiota 
in stimulating host immunity will be discussed in two parts: i) Role of microbiota in 
intestinal immunity and ii) Role of microbiota in systemic immunity. The mechanism 
by which host immunity protects itself from attack by the commensal bacteria will be 
discussed in part (i). 
 
Role of microbiota in endemic immunity 
As mentioned earlier, humans and other warm-blooded animals are colonized by a 
commensal microbiota at specific anatomical sites like skin, oral cavity, respiratory 
tract, conjunctiva and the gut. Among these sites, the microbiota is particularly 
important in stimulating local immunity in the gut and skin.  
Establishment of intestinal immunity: At the forefront of intestinal immunity is the 
intestinal epithelium, which is composed of a single layer of intestinal epithelial cells 
(IECs)171,172. Beneath the epithelium lies the supporting loose connective tissue called 
the lamina propria, which is composed of stromal cells, and diverse lymphoid and 
myeloid cell populations. The lymphoid tissue associated with the intestinal lamina 
propria and epithelium is called the gut associated lymphoid tissue (GALT). Beneath 
the lamina propria, lies the muscular mucosa (Figure 1.5). 
Anatomically, the small intestinal mucosa is organized into millions of projections 
called villi and intervening invaginations called crypts, each of which is dominated by 
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Figure 1.5 
Figure 1.5: The intestinal Immune System 
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a distinct cell type. The luminal surface of the intestinal epithelium, which comprises of 
microvilli along with the overlying mucus is called the brush border. IECs are simple 
columnar and non-ciliated cells that line the intestine.  They are interconnected by tight 
junctions at the basal and apical surfaces, which makes the membrane and the 
paracellular spaces impenetrable to macromolecules, even 2-kDa molecules. Certain 
inflammatory conditions cause ‘leaky’ tight junctions that facilitate the underlying 
lymphoid tissue to mount a response to dietary antigens and commensal flora173. IECs 
are highly polarized cells with an apical surface facing the intestinal lumen and a 
basolateral surface facing the lamina propria.  IECs are actually composed of four 
different cell types, all of which are derived from a common stem cell progenitor, the 
small intestinal epithelial progenitor. Amongst them, goblet cells and paneth cells have 
functions in immunology; in making mucus and antimicrobial peptides respectively.  
Mucus provides a physical barrier that separates the microbiota from the apical side of 
the epithelium, a process called as non-immune exclusion174. Mucus also provides 
anchorage to gut flora via IgA antibodies.  
 
GALT: Intestinal epithelium plays a critical role in gut ‘innate’ immunity by mediating 
non-immune exclusion, i.e., preventing antigen access to the underlying lymphoid 
tissue and also through production of anti-microbial peptides. But a slower and more 
specific response to gut antigens, which is characteristic of an adaptive immune 
response, is enabled by the specialized lymphoid tissue associated with GI tract called 
GALT175. The GALT consists of discrete inductive and effective sites (Figure 1.5). The 
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inductive sites are organized lymphoid follicles that include the peyer’s patches (PP) 
and mesenteric lymph nodes and other smaller lymphoid follicles, which are scattered 
throughout the wall of the small and large intestine. At the luminal surface, PPs are 
surrounded by a distinct type of epithelium called the follicle-associated epithelium 
(FAE). FAE is adapted to function in immunity. Unlike the intestinal epithelium it has 
lower absorptive and digestive capacity but is infiltrated by large numbers of B cells, T 
cells, macrophages and dendritic cells (DCs). In addition to these lymphoid cells, FAE 
also contains specialized epithelial cells called M (or microfold) cells which actively 
take up macromolecules and microorganisms from the luminal side and transfer it to 
antigen presenting cells (APCs) either in the epithelium or the underlying dome 
region171.  
As in other secondary lymphoid tissue sites, PPs contain 6-12 basally located germinal 
centers. Germinal centers contain B cells and CD4 T cells, some apoptotic lymphocytes 
as also APCs such as dendritic cells, macrophages and a specialized stromal cell known 
as a follicular dendritic cell (FDC). APCs process antigens and present them to T cells, 
leading to their activation. Mucosal T cells stimulate the differentiation of B cells into 
plasma cells and their subsequent isotype switching to IgA producing cells. 
Lymphocytes that are primed in the PPs get drained into the mesenteric lymph nodes 
(MLNs). They leave the MLN through the efferent lymph and enter the bloodstream 
through the thoracic duct and eventually accumulate in the mucosa. 
Alternatively, the process of antigen-dependent T cell activation might occur in the 
MLNs when antigen or antigen-loaded DCs in the PPs enter the draining lymph176.  
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On activation in the PPs or MLNs, T cells and IgA-producing B cells migrate into the 
effector sites. Effector sites are scattered throughout the mucosa in the lamina or 
substantia propria. Effector sites are composed of T cells, which are mostly CD4+, IgA 
plasma cells with fewer IgG and IgM plasma cells, and few B-cells, dendritic cells, and 
macrophages. At the effector sites, polymeric IgA is secreted across the mucosal 
epithelium into the lumen with the help of polymeric IgA receptor, which is expressed 
in mucosal epithelial cells. Secreted IgA play a role in innate immunity by preventing 
access of microbial pathogens to the mucosal epithelium. In addition, this antibody 
provides specific immunity against certain enteric pathogens177.  
Locally resident intra epithelial lymphocytes (IELs) are distinguished from the systemic 
T cells by their subset composition. TCRγδ+ cells constitute around 50% of murine 
CD8+ intestinal cells178. All IELs are cytolytic and function in a granzyme or Fas 
dependent fashion and also by secreting T helper 1 (TH1) cytokines. TCRγδ+ cells 
promote epithelial tissue repair upon injury and prevent microbial invasion of normal or 
injured tissue179.  
Gut flora is indispensible in the maintenance of GALT and the intestinal epithelium, so 
much so that GF animals have poorly developed PPs and isolated lymphoid follicles, 
fewer plasma cells and IELs with reduced functionality, little production of 
antimicrobial peptides and IgA180. The molecular mechanisms by which microbiota 
influence these aspects of immune machinery are only partially known. Some of them 
involve activating the known PRR pathways and will be discussed in the forthcoming 
sections. 
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Maintenance of intestinal epithelium integrity under steady state and on injury: 
Mature IECs continuously arise from the colonic epithelial progenitors (ColEPs), which 
are present in the lower half of colonic crypts. Differentiated IECs migrate from the 
crypt base to the upper regions where they undergo apoptosis and/or exfoliation. It has 
been shown that TLR signaling by commensal flora is important to maintain a balance 
of proliferation and differentiation in the colonic crypts under homeostatic conditions. 
MyD88-/- mice have an expanded proliferative zone, which extends to the differentiated 
crypt orifice and also have an increased number of total proliferating cells181. In 
addition to a defect in basal maintenance of intestinal epithelium, commensal flora 
induced TLR-MyD88 signaling also has a dramatic role in tissue repair and survival 
after intestinal injury and inflammation181.  
Development of inductive sites of intestinal immunity: As discussed before, inductive 
sites in the murine intestinal immune system are comprised of organized tissues like the 
PPs and MLNs as well as clusters of loosely packed lymphocytes called isolated 
lymphoid follicles (ILFs). The embryonic genesis of PPs is critically dependent upon 
lymphotoxin and interleukin-17 (IL-17) signaling, but largely independent upon the 
presence of gut flora182. However, the presence of intestinal flora is essential during 
post-natal development of PPs. Germ-free mice have smaller and fewer PPs with 
indistinct germinal centers. This effect is likely to be mediated via the TLR4-MyD88 
signaling pathway, as PPs in MyD88-/- and TLR4-/- mice were significantly smaller than 
their wild type counterparts183. Gut flora is also absolutely critical for the genesis of 
ILFs184.  
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IgA production: Secretory IgA is important as an effector molecule in the adaptive 
immune response against enteric pathogens. Moreover, mice deficient in production of 
IgA also show an altered composition of gut microbiota. Interestingly, germ-free mice 
have lowered IgA numbers indicating that there is a feedback loop between secretion of 
IgA and symbiotic bacteria. The gut flora directs the expression of inducible nitric 
oxide synthase in dendritic cells of mucosal tissue. iNOS+ dendritic cells stimulate Ig 
class switching to IgA in a T-cell-dependent and independent fashion185.  
Production of antimicrobial peptides: Antimicrobial peptides are evolutionary 
conserved small molecular weight proteins that have broad-spectrum activity against 
bacteria. As mentioned before, paneth cells are the primary producers of these peptides 
in the intestine.  
Intestinal flora induces the expression of several antimicrobial peptides like REG3γ and 
REG3β (both of which bind peptidoglycan), CRP-ductin (which targets gram-positive 
and gram-negative bacteria), RELMβ (which is an inflammatory modulator) and also 
members of the α-defensin family by isolated paneth cells186. Moreover, paneth cells 
directly sense intestinal flora using the TLR-MyD88 signaling axis leading to a 
concomitant increase in expression of these peptides. 
Interestingly, there exists a negative feedback loop between the presence of intestinal 
microbiota and the paneth cell-MyD88-dependent expression of antimicrobial 
peptides187. While gut flora stimulates the production of antimicrobial peptides, the 
latter act to limit bacteria penetration and dissemination across the intestinal epithelium.  
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Establishment of the TH17/Treg axis: Commensal bacteria play an important role in the 
development and maintenance of various pro-inflammatory (TH1,TH2, and TH17) and 
anti-inflammatory (Treg) subsets of T cells. TH17 cells are present in the small intestinal 
lamina propria and important for defense against bacterial and fungal pathogens. 
Certain species of the microbiota called segmented filamentous bacteria have been 
shown to induce the production of TH17 cells188. This process is dependent upon the 
secretion of serum amyloid A in the terminal ileum that acts on the lamina propria 
dendritic cells. These dendritic cells then produce cytokines that promote development 
of intestinal TH17 cells. 
Likewise, the differentiation of inducible Tregs is critically dependent upon gut flora189.  
Inducible Tregs occur in the peripheral tissues like gut instead of the thymus. A single 
molecule polysachharide A (PSA), which is a zwitterionic capsular polysaccharide of 
the gut organism Bacteroides fragilis is able to restore the production of inducible Tregs 
in the gut in germ-free mice. This process is dependent upon TLR2 signaling. These 
Tregs are CD4+Foxp3+ and inhibit inflammation by their secretion of IL-10. 
Furthermore, in the experimental mouse models of colitis, monocolonization with 
Bacteroides fragilis is able to protect mice from inflammation and mortality.  
 
Role of microbiota in systemic immunity 
Compared to the study of the role of gut flora in intestinal flora, relatively less is known 
about how intestinal flora affects systemic immunity. Following are some of the 
pathways influenced by intestinal flora.  
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Maintaining TH1/TH2 balance: Germ free mice have a systemic defect in their effector 
CD4+ T cells numbers and exhibit a TH1/TH2 imbalance190. Mazmanian et al show that 
in the absence of intestinal flora, splenic CD4+ T cells make more interleukin-4 (IL-4) 
and low levels of IFN-, which is characteristic of a TH2 response. This overproduction 
of IL-4 is associated with TH2 mediated thymic pathologies in germ free mice.  
PSA, which is the capsular polysaccharide of the gut organism Bacteroides fragilis is 
able to restore T helper cell balances in germ free mice190. PSA is phagocytosed and 
processed by dendritic cells and presented to CD4+ T cells. Monocolonization by B. 
fragilis is sufficient to revert the cytokine profile in germ free mice to that of SPF mice. 
Priming neutrophils for opsonophagocytosis: As described earlier, neutrophils kill 
microbes by oxidative and non-oxidative mechanisms. A recent study has shown that 
efficient phagocytosis of bacteria like S. aureus and S. pneumonia by neutrophils 
requires priming by intestinal flora191. Peptidoglycan derived from gut flora translocates 
through the intestinal epithelium and enters the circulation from where it can diffuse 
into tissues. Commensal bacteria-derived peptidoglycan then primes bone marrow and 
blood residing neutrophils via NOD1 signaling. Consequently, neutrophils from NOD1 
deficient animals are defective in killing bacteria.
Priming acute inflammation: Souza et al., Fagundes et al., and Amaral et al. have 
shown that germ free mice have reduced neutrophil accumulation in some models of 
inflammation like ischemia and reperfusion injury192-194. In these studies, defective 
neutrophil infiltration has been attributed to the overproduction of IL-10 by these 
animals. However, a study of the role of intestinal flora in regulating the acute 
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inflammatory response, in the absence of a breach in intestinal mucosa is desired. 
1.2.4. Germ free animals                                                                                  
The study of role of microbiome in host physiology is indebted to the breeding strategy 
developed by Dr. James Reyniers at the University of Notre Dame166. Mice pups are 
derived germ-free by cesarean section. Pups developing in the uterus of a healthy 
mother are free of bacteria. The uterus is removed aseptically from pregnant mothers, 
briefly sterilized and the pups are then transferred to germ-free isolators. During the 
initial development of germ free mice, these pups were nurtured and fed by hand 
rearing. With the availability of “primer” germ-free mice now, they are fed by lactating 
germ-free mothers.  
The germ-free isolators consist of sterile plastic chambers. Air blown into the chamber 
is sterilized by filters. The interiors of the chamber are treated with chlorine dioxide. 
Mouse feeding and other supplies are autoclaved before entry into the chamber. 
The sterility of germfree mice is assessed by performing a quantitative PCR for 16S 
rRNA and also by thioglycolate culturing of the cecal contents195.
Germ-free animals bred in this fashion, do not have any bacteria in the intestine or on 
other body surfaces. This is in contrast with specific-pathogen-free (SPF) mice that are 
only devoid of known mouse pathogens and do contain intestinal bacteria. 
 
 
 
48
1.2.5. Regulation of the Acute Inflammatory Response by Gut flora 
The idea that commensal flora could regulate the inflammatory pathway germinated 
from a conundrum faced in the field of inflammasome activation. In vitro, macrophages 
generate mature IL-1β upon stimulation with NRLP3 ligands e.g. silica, ATP, nigericin 
etc. (Signal 2), only when they are pre-stimulated by a TLR agonist (Signal 1)196. 
However, in vivo, an intraperitoneal injection of crystals (e.g. silica) is sufficient to 
elicit an IL-1β-dependent neutrophil migration142. What stimulus serves as “Signal 1” 
in vivo? We hypothesized that ligands derived from commensal flora constitutively 
prime macrophages so that they poised to generate IL-1β when stimulated with any 
NRLP3 ligand.  
We sought to test this hypothesis using germ-free mice. Consistent with our hypothesis, 
germ-free mice showed markedly reduced inflammation to silica, and monosodium 
crystals. But on further probing, we found that germ-free mice had a generalized defect 
in mounting an inflammatory response to many ligands like zymosan, dead cells, 
thioglycollate etc. Since zymosan stimulates neutrophil migration in an IL-1R-
independent way, the defect in germ-free mice appeared to be broader, beyond the 
activation of inflammasomes.  
There have been some reports of germ-free mice showing a defect in the acute 
inflammatory responses to pathogens and sterile injury. However, a thorough 
mechanistic study of how intestinal bacteria regulate inflammation was desired. As 
discussed in the before, the acute inflammatory response involves multiple steps of 
neutrophil activation, chemotaxis and phagocytosis. We sought to examine the precise 
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step at which gut flora influence the inflammatory pathway. In addition, bacteria 
activate a variety of known intracellular signaling pathways. We sought to identify the 
primary signaling pathway employed by commensal flora to prime acute inflammation. 
The main focus of the second chapter is addressing these questions pertaining to the 
role of intestinal flora in immunity. 
The third and the fourth chapter focus on investigating the mechanism of IL-1 signaling 
during cell death-induced inflammation. Previous work published in the laboratory has 
demonstrated the crucial role of IL-1 in cell death-induced neutrophil migration197. 
However, questions regarding the cellular source of IL-1 as well as cellular target of IL-
1 signaling remain unresolved. This thesis contributes to the progress achieved in the 
laboratory in understanding these processes.  
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ROLE OF INTESTINAL FLORA IN REGULATING THE ACUTE 
INFLAMMATORY RESPONSE 
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2.1. Introduction 
The large intestinal tract of humans and other vertebrates is inhabited by numerous and 
diverse bacterial populations. The extent of microbial colonization is such that the 
number of microbial cells outnumbers the total number of cells in the human body by 
10-fold. The combined microbial gene set similarly exceeds the human gene 
complement by about 150-fold198,199. As such, intestinal flora plays a vital role in the 
gut physiology. The mammalian digestive system is limited in its ability to produce all 
the enzymes, which would be required to metabolize the vast repertoire of energy 
substrates that are consumed200. Gut flora complements the host’s digestive system in 
maximizing their utilization. The nutritive benefits of gut flora extend to carbohydrate 
fermentation and absorption, lipid storage and secretion of vitamins and amino acids 
and absorption of minerals200. Besides their role in digestion, intestinal flora contributes 
to intestinal epithelial cell growth and proliferation and development of immunity. 
Mice bred in germ-free conditions are more susceptible to pathogens like Salmonella 
enterica , Listeria monocytogenes , Klebsiella pneumonia  and Candida albicans 193,201-
203. The role of intestinal flora in preventing enteric infections was attributed to its 
ability to prevent invasion and colonization by opportunist pathogens in the intestinal 
niche. However, in recent years it has become increasingly apparent that the host 
microbiota plays a more active role in the development and functioning of immune 
system. Germ-free mice have anatomical defects in the gut-associated lymphoid tissue 
like poorly developed Peyer’s patches, isolated lymphoid follicles, plasma cells and 
fewer intraepithelial lymphocytes180,184,204,205. They also produce lower levels of 
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antimicrobial peptides and IgA204,206. Certain species of the microbiota, namely 
segmented filamentous bacteria have been shown to induce the production of TH17 
cells in the small intestinal lamina propria188. Likewise, the gut organism Bacteroides 
fragilis facilitates the production of inducible Tregs in the gut189. Hence, commensal 
microbiota are pivotal for the development of gut-associated immunity. 
Recent studies have demonstrated that gut flora have more far-reaching effects on the 
host innate and adaptive systemic immunity. Germ free mice have a systemic defect in 
the proliferation of effector CD4+ T cells numbers and exhibit a TH1/TH2 imbalance. 
Mazmanian et al show that in the absence of intestinal flora, splenic CD4+ T cells make 
more interleukin-4 (IL-4) and low levels of IFN-γ, which is characteristic of a TH2 
response190. Commensal flora has been shown to prime bone marrow and blood 
neutrophils so that they can function effectively in the phagocytosis of Streptococcus 
pneumoniae and Staphylococcus aureus191. However, a better understanding of how 
intestinal flora prime innate inflammatory responses in vivo is desired. In this study, we 
sought to determine the contribution of intestinal flora in regulating neutrophil 
migration during the acute inflammatory response.  
Acute inflammatory response is caused by the rapid recruitment of leukocytes, mainly 
neutrophils, from the blood to the tissue site. Diverse agents including invading 
pathogens, injured or dead cells and other irritants like crystals may stimulate this 
response. These inflammatory agents are sensed by tissue-resident cells like 
macrophages, dendritic cells, and mast cells. The latter, once activated, release 
inflammatory mediators like histamines, prostaglandins and cytokines like IFN-γ, IL-8, 
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TNF-α and IL-1. These mediators promote vasodilation and also activate the 
endothelium, facilitating the chemotactic transmigration of leukocytes, mainly 
neutrophils into the affected tissue.  
Neutrophils, once recruited to the site of infection, are powerful phagocytes that kill 
microbes by oxidative (e.g., reactive oxygen species) and non-oxidative (e.g., various 
proteases) mechanisms207. The importance of neutrophil function is evident in 
individuals who have a defect in neutrophil chemotaxis or phagocytic functions155,156. 
These individuals are more prone to bacterial infections. However, in some instances, 
the neutrophil response can be counterproductive to the host. Microbicidal molecules 
released from activated neutrophils can cause damage to bystander healthy tissue. The 
consequent cell injury and death can aggravate the inflammatory condition, 
exacerbating the damage. This situation is particularly relevant when the inciting 
stimuli are sterile particles like crystals. The accumulation of crystals may not be as 
harmful to the host as the collateral damage caused by recruited neutrophils. Hence it is 
essential to study the factors controlling neutrophil migration and activation.  
Using germ-free and antibiotic-treated mice we found that intestinal flora are 
indispensible to mediate neutrophil and monocyte recruitment to diverse pathogen-
derived and sterile particles. In the absence of microbiota, neutrophils can migrate from 
the bone marrow to the bloodstream but fail to extravasate from blood into the inflamed 
tissue. Neutrophil infiltration into tissues requires priming by microbiota, which occurs 
in a MyD88-dependent fashion. For neutrophil extravasation into tissues, gut flora-
activated MyD88 signaling is crucial during the development of immune system but 
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depending upon the ligand, may be dispensable at the time of the actual inflammatory 
challenge. Pre-treatment of antibiotic-treated mice with a purified MyD88 agonist is 
sufficient to restore neutrophil migration. Furthermore, after inflammatory stimulation, 
antibiotic-treated mice are capable of making pro-inflammatory cytokines yet are 
defective in tissue neutrophil infiltration. Contrary to previous reports193, the reduced 
neutrophil infiltration observed in antibiotic-treated mice cannot be attributed to their 
excessive production of IL-10. In summary, this study provides insight into the precise 
role of microbiota in mediating acute inflammation.  
 
2.2. Results 
Germ free and antibiotic-treated mice have a defect in neutrophilic inflammation. 
To investigate the role of commensal microflora in acute inflammation, we examined 
the recruitment of neutrophils to various stimuli in the peritoneal cavity in mice bred in 
germ-free conditions. This was done using the peritonitis model of inflammation 
(Figure 2.1). We found that germ-free (GF) mice showed a dramatic reduction in the 
number of infiltrating neutrophils as compared to specific pathogen free (SPF) mice in 
the peritoneum after inflammatory stimulation. This defect in acute inflammation was 
observed to challenge with microbial components like zymosan, a component of yeast 
cell wall and thioglycollate (Figure 2.2 A and B) as well as to sterile ligands like silica 
and monosodium urate crystals (Figure 2.2 C and D). In subsequent experiments we 
focused on analyzing the responses to zymosan because this agent was easy to 
administer and gave strong and consistent results.  
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Figure 2.1 
Figure 2.1: Outline of the peritonitis assay used to study the acute inflammatory 
response 
This assay was used to quantify the recruitment of neutrophils and to determine the 
amount of cytokines produced in the peritoneum after challenge with microbial/sterile 
stimuli. 
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Figure 2.2 
 
Figure 2.2: Mice lacking intestinal flora are defective in neutrophil recruitment to 
diverse inflammatory stimuli 
Total neutrophil numbers in the peritoneum of SPF C57BL/6 and germ-free (GF) 
C57BL/6 mice 4h after i.p. injection of (A) 0.2mg zymosan, (B) 1mL 3% thioglycollate 
(C) 0.5mg silica crystals, and (D) 0.5mg monosodium urate (MSU) crystals. Numbers 
of neutrophils were determined by multiplying total cell number by percentage of Ly-
6G+ 7/4+. All data are combined results of three or more experiments and represented as 
mean ± SEM. n = Total number of mice used per datum group. In all panels PBS group 
represents SPF C57BL/6 mice challenged with PBS and lavaged after 4h. * P < 0.0001, 
** P = 0.0025, ***P = 0.04 versus SPF animals 
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This phenotype of reduced inflammation observed in germ-free animals was replicated 
in mice treated with a cocktail of broad-spectrum antibiotics from birth to the time they 
were used in experiments (Day 0 to Day 45) (Figure 2.3 A); microbial 16S ribosomal 
RNA was undetectable by PCR in these animals indicating that had severely reduced 
microbial flora, as has been described by others (Figure 2.4) 208. Because of the limited 
availability of germ-free mice, most subsequent experiments were done using 
antibiotic-treated mice. 
The lowered numbers of neutrophils observed in the peritoneum in antibiotic-treated 
mice after 4 hours was not due to delayed migration of neutrophils, because these mice 
exhibited defective neutrophil migration even after 16 hours after inflammatory 
challenge (Figure 2.3 B). We sought to examine the precise step at which microbiota 
regulate neutrophil activation and migration. Neutrophils originate and mature in the 
bone marrow207. Mature neutrophils subsequently leave the bone marrow and circulate 
in the blood stream. Cytokines generated at the site of inflammation stimulate an 
increase in production of neutrophils in the bone marrow and their release into the 
blood stream and chemotactic factors promote their subsequent migration into the 
inflamed area. 
 
 
 
 
 
59
Figure 2.3 
 
 
Figure 2.3: Mice having reduced intestinal flora (antibiotic-treated mice) are 
defective in neutrophil recruitment to inflammatory stimuli 
(A, B) Total neutrophil numbers in the peritoneum of SPF C57BL/6 and antibiotic-
treated C57BL/6 mice after i.p. injection of 0.2mg zymosan and lavaged after (A) 4h. 
(B) 16h after injection. Antibiotic-treated mice were subjected a cocktail of antibiotics 
(ampicillin, neomycin, vancomycin and metronidazole) from birth to day of 
experimental use. All data are combined results of two or more experiments and 
represented as mean ± SEM. In both panels PBS group represents SPF C57BL/6 mice 
challenged with PBS and lavaged after 4h or 16h. * P =0.008 versus SPF animals. 
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Figure 2.4 
Figure 2.4: qPCR to determine the efficiency of antibiotic treatment 
The bacterial load in the colonic contents of specific pathogen free (SPF) vs antibiotic-
treated (AB) was quantified by determining the number of copies of bacterial 16S RNA 
by qPCR. 
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We observed that antibiotic-treated mice have a substantial reduction in the basal 
number of neutrophils both in the bone marrow and in the blood stream in the absence 
of any stimulation (Figure 2.5 A and B). However, when antibiotic-treated mice were 
challenged with zymosan, the total blood count of neutrophils was substantially higher 
than that of their SPF counterparts (Figure 2.5 C). Since this change in neutrophil 
number occurs rapidly, these data indicate that there is not actually a defect in the 
number of neutrophils present in the periphery of antibiotic-treated mice. Presumably 
there is a larger pool of marginated cells in the antibiotic-treated mice compared to 
control mice, which is then rapidly mobilized upon challenge with zymosan. Antibiotic-
treated mice had similar percentages of mature neutrophils in the bone marrow and 
blood (before and after administration of zymosan) as SPF controls as assessed by their 
expression of Ly-6G and CD11b (Figure 2.6 A, B, and C). This suggested a role for 
intestinal flora in influencing the extravasation of neutrophils from the blood stream 
into the inflamed tissue site.  
Neutrophil extravasation through blood vessels into tissues is facilitated by cell 
adhesion molecules expressed by neutrophils and the endothelium. Neutrophils in blood 
of antibiotic-treated animals showed similar or (higher) percentages and mean 
fluorescence intensity of cell adhesion molecules like CD44, CD62L, and the 
chemokine receptor, CXCR2 (Figure 2.7 A-F). We next examined if antibiotic-treated 
mice were able to recruit neutrophils when treated with macrophage inflammatory 
protein-2 (MIP-2), a chemotactic factor for neutrophils.  
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Figure 2.5 
 
Figure 2.5: Antibiotic-treated mice appear to have a specific defect in the 
recruitment of neutrophils from the blood into the inflamed tissue 
(A, B) Total number of neutrophils in the (A) bone marrow and (B) 1 mL blood in 
unstimulated SPF C57BL/6 and antibiotic-treated C57BL/6 mice. (C) Total number of 
neutrophils in 1 mL blood after 4 h of zymosan challenge. (D) Total number of 
neutrophils in the peritoneum of SPF C57BL/6 and antibiotic-treated C57BL/6 mice 
after intraperitoneal challenge with 5 ng of recombinant murine MIP-2. All data are 
combined results of three or more experiments and represented as mean ± SEM. n = 
Total number of mice used per datum group. ** P = 0.0022, Not significant (N.S.) 
versus SPF animals. 
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Figure 2.6 
 
 
 
 
Figure 2.6: Antibiotic-treated mice do not have a defect in maturation of 
neutrophils in the bone marrow  
(A, B, C) % of mature neutrophils in SPF C57BL/6 and antibiotic-treated C57BL/6 
mice as assessed by their expression of Ly6G and CD11b by FACS analysis in (A) 
bone marrow of unstimulated mice (B) peripheral blood of unstimulated mice (C) 
peripheral blood of mice stimulated in 0.2mg zymosan. The % of mature neutrophils 
was calculated as total number of CD11b+Ly6G+ cells/total number of CD11b+Ly6G- 
and CD11b+Ly6G+ cells X 100. All data are combined results of two or more 
experiments and represented as mean ± SEM. 
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Figure 2.7 
 
 
Figure 2.7: Neutrophils in antibiotic-treated mice are not defective in their 
expression of cell adhesion molecules and can extravasate in response to an 
intraperitoneal challenge with MIP-2 
(A- C) % of neutrophils in blood from zymosan-stimulated SPF or antibiotic-treated 
C57BL/6 mice expressing (A) CXCR2 (B) CD44 (C) CD62L. (D- E) Mean 
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fluorescence intensity (MFI) of neutrophils in blood from zymosan-stimulated SPF or 
antibiotic-treated C57BL/6 mice for their expression of (D) CXCR2 (E) CD44 (F) 
CD62L. (G) Total number of neutrophils in the peritoneum of SPF C57BL/6 and 
antibiotic-treated C57BL/6 mice after intraperitoneal challenge with 5 ng of 
recombinant murine MIP-2. All data are combined results of three or more experiments 
and represented as mean ± SEM. n = Total number of mice used per datum group. *P= 
0.0143, *** P = 0.0002, Not significant (N.S.) versus SPF animals. 
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We challenged the mice with purified recombinant MIP-2 protein in the amount that is 
produced in the peritoneum after zymosan challenge. We found these mice were able to 
mount a neutrophil response in the peritoneum as well as the SPF mice (Figure 2.7 G). 
Our data showing normal neutrophil migration to MIP-2 in antibiotic-treated mice is 
consistent with the observation that neutrophils from these mice had normal levels of 
CXCR2, since CXCR2 is the physiological receptor for MIP-2. This showed that mice 
lacking microbial flora do not have a generalized defect in the endothelial vasculature 
and also that neutrophils from these mice are functionally capable of migrating to the 
inflamed tissue upon receiving the appropriate signals.  
 
The production of cytokines in antibiotic-treated mice. 
In the peritoneum, resident macrophages have been shown to sense proinflammatory 
stimuli and produce cytokines that initiate inflammation153. Therefore, we quantified 
the number of resident macrophages (CD11b +, F4/80 + cells) in the peritoneum and 
found that they were similar in both SPF and antibiotic-treated mice (Figure 2.8 A). 
Moreover, peritoneal cells from antibiotic-treated mice were as efficient as those from 
SPF mice in their phagocytosis of zymosan (Figure 2.8 B), which was consistent with 
previous reports209. 
We next quantified the cytokines produced in the peritoneum in SPF and antibiotic-
treated mice after they were injected with zymosan. Surprisingly, the peritoneal levels 
of the pro-inflammatory cytokines TNF-α and IL-6 as well as the neutrophil-recruiting 
chemokines MIP-2 and KC were significantly higher in zymosan-injected antibiotic-
67
treated mice as compared to their SPF controls (Figure 2.9 A-D). This showed that 
antibiotic-treated mice were capable of sensing zymosan and causing local activation of 
cells to produce inflammatory cytokines and that there was no apparent defect in this 
process. Even more surprising was the observation that when antibiotic-treated mice 
were injected an equivalent amount of purified MIP-2 as was made in situ, their 
neutrophil responses were equivalent to wild type mice. Taken together these results 
suggest upon injecting proinflammatory stimuli into antibiotic-treated mice, there is 
something that inhibits responses to the proinflammatory cytokines that are produced. 
An earlier report had suggested that germ-free mice overproduced the inhibitory 
cytokine IL-10 and that this could inhibit immune responses193. Consistent with that 
study we found that antibiotic treated animals make 2-fold more IL-10 than SPF 
controls (Figure 2.10 A). To test whether the IL-10 was responsible for the reduced 
responses in the antibiotic-treated mice we pre-treated antibiotic treated mice with the 
Interleukin-10 receptor (IL-10R) neutralizing antibody. This treatment augmented 
responses in both control and antibiotic-treated mice, indicating that the antibody 
blocked the effect of IL-10  receptor signaling. However, blocking IL-10 receptor 
signaling in antibiotic-treated mice failed to restore neutrophilic recruitment to the level 
of IL-10R antibody-treated SPF controls after zymosan challenge (Figure 2.10 B). This 
shows that inhibiting IL-10R in general enhances neutrophil numbers on an 
inflammatory challenge, even in SPF controls, but that production of IL-10 does not 
fully account for the reduced inflammation phenotype observed in antibiotic-treated 
mice. 
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Figure 2.8 
 
Figure 2.8: Antibiotic-treated mice do not have a defect in either the numbers of 
resident peritoneal macrophages or their capacity to phagocytose zymosan 
(A) Total number of resident peritoneal macrophages in unstimulated SPF C57BL/6 
and antibiotic-treated C57BL/6 mice. Numbers of resident macrophages was 
determined by multiplying total cell number by percentage of CD11b+ F4/80+ cells. (B) 
Efficiency of phagocytosis of zymosan by resident peritoneal macrophages isolated 
from unstimulated SPF C57BL/6 and antibiotic-treated C57BL/6 mice. Peritoneal cells 
were incubated with FITC-conjugated zymosan solution for 45 min at 37°C. The 
reaction was terminated by transferring the plate to 4°C. In the control group, cells were 
incubated with zymosan at 0°C throughout the incubation. After washing unbound 
zymosan, cells were scraped off the plate and resuspended in tryphan blue to quench 
cell surface-bound zymosan. The efficiency of phagocytosis was termed as 
‘phagocytosis index,’ which was calculated as % of macrophages that have taken up 
zymosan X MFI of macrophages. n = Total number of mice used per datum group. All 
data are combined results of two or more experiments and represented as mean ± SEM.  
69
Figure 2.9 
Figure 2.9: Reduced neutrophil recruitment in antibiotic-treated mice is not due to 
lower production of pro-inflammatory cytokines in the peritoneum 
(A - D) SPF C57BL/6 and antibiotic-treated C57BL/6 mice were challenged with 
zymosan intraperitoneally and 4h post-injection lavaged with 2ml buffer. The 
concentrations of (A) TNF-α (B) IL-6 (C) MIP-2 (D) KC in the lavage buffer was 
quantified by ELISA. All data are combined results of three or more experiments and 
represented as mean ± SEM. * P < 0.0001, ** P = 0.0006 versus SPF animals. 
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Figure 2.10 
Figure 2.10: Reduced neutrophil recruitment in antibiotic-treated mice is not due 
to higher production of IL-10 in the peritoneum  
(A) SPF C57BL/6 and antibiotic-treated C57BL/6 mice were challenged with zymosan 
intraperitoneally and 4h post-injection lavaged with 2ml buffer. The concentration of 
IL-10 in the lavage buffer was quantified by ELISA. (B) Mice were pre-treated twice 
with either IL-10 receptor neutralizing antibody or control antibody before challenging 
them intraperitoneally with 0.2mg of zymosan. Mice were lavaged after 4h and the 
numbers of neutrophils in the peritoneum was quantified by flow cytometry. All data 
are combined results of two or more experiments and represented as mean ± SEM. * P 
=0.04, ** P = 0.04, *** P = 0.001, Not significant (N.S.) versus SPF animals.  
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Intestinal flora prime neutrophilic inflammation via MyD88 signaling pathway. 
We hypothesized that microbiota mediate their effects on inflammatory response by 
activating pattern recognition receptor (PRR)-signaling pathways. To test this 
hypothesis, we analyzed mice deficient in the known PRR pathways and examined their 
ability to mount neutrophil response to an intraperitoneal zymosan challenge. Receptor 
interacting protein-2 (RIP-2) knockout mice, which are defective in nucleotide-binding, 
oligomerisation domain-containing protein-1 (NOD1) or NOD2 signaling, were able to 
respond normally to zymosan (Figure 2.11 A). Similar results were obtained in 
mitochondrial antiviral signaling (MAVS) knockout mice, which were defective in 
retinoic acid-inducible gene-I (RIG-I) and melanoma differentiation-associated gene 5 
(MDA5) signaling. Similarly, no defects were found in mice lacking caspase 1, 
NLRP3, and ASC knockout mice, which are defective in inflammasome activation 
(Figure 2.11 A). However, myeloid differentiation primary response gene (MYD88) 
knockout mice showed a markedly reduced recruitment of neutrophils following 
zymosan stimulation (Figure 2.11 B), similar to that observed in the antibiotic-treated 
mice. Similar to antibiotic-treated animals, MyD88 knockout mice had a basal 
impairment in the number of neutrophils in the bone marrow and blood (Figure 2.12 A, 
B). Furthermore, on challenge with zymosan, neutrophils in the bloodstream of Myd88-
/- mice outnumbered that in wild-type mice (Figure 2.12 C). This showed that MyD88 
knockout mice had a possible defect in the specific passage of neutrophils from the 
blood to the site of injury.   
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Figure 2.11 
 
 
 
Figure 2.11: Zymosan-induced neutrophil recruitment requires MyD88 signaling 
but is independent of TLR2/4 or IL-1R signaling 
(A, B) Total neutrophil numbers in the peritoneum of (A) SPF C57BL/6 (WT), ASC-/-, 
Caspase 1-/-, NLRP3-/-, RIP2-/-, and MAVS-/- mice and (B) SPF C57BL/6 (WT), MyD88-
/-, TLR2-/-, and IL-1R-/- mice. Mice were injected with 0.2mg zymosan and lavaged after 
4 h. Numbers of neutrophils was determined by multiplying total cell number by 
percentage of Ly-6G+ 7/4+. All data are combined results of two or more experiments 
and represented as mean ± SEM. n = Total number of mice used per datum group. The 
PBS group represents SPF C57BL/6 mice challenged with PBS and lavaged after 4h. * 
P < 0.0001, Not significant (N.S.) versus SPF animals.  
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Figure 2.12 
 
 
 
 
Figure 2.12: MyD88-/- mice have a specific defect in extravasation of neutrophils 
from the bloodstream to the site of injury 
(A, B) Total number of neutrophils in the (A) bone marrow and (B) 100µL blood in 
unstimulated wild type (WT) and MyD88-/- mice. (C) Total number of neutrophils in 
100µL blood after 4h of zymosan challenge. All data are combined results of two or 
more experiments and represented as mean ± SEM.  
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MyD88 is an adaptor protein for TLRs and some cytokine receptors, most notably the 
IL-1R. TLR2 has been reported to be one of the receptors for zymosan and it was 
possible that this was why MyD88 was required for the inflammatory response to this 
agent210. However, we found that TLR2-deficient mice had a normal zymosan-induced 
infiltration of neutrophils in the peritoneum (Figure 2.11 B). IL-1 is a proinflammatory 
cytokine that plays a key role in recruiting neutrophils to sites of inflammation in 
response to some inflammatory stimuli. However, we had previously shown that the 
neutrophilic inflammatory response to zymosan does not require the IL-1R and we 
confirmed again that this was the case (Figure 2.11 B). Therefore the requirement for 
Myd88 in the response to zymosan was not as an adaptor protein for TLR2 or IL-1R 
signaling.  
We next sought to determine whether MyD88 was needed during the elicitation of the 
inflammatory response or was needed earlier to somehow condition the innate immune 
response so as to be responsive to the proinflammatory stimulus. We observed that 
intestinal flora influences acute inflammation during the initial development of mouse 
immune system because adult 6-week old mice treated with antibiotics did not show a 
defect in neutrophil migration (data not shown), unlike animals treated with antibiotics 
right from birth. Hence, we hypothesized that the expression of MyD88 in tissues is 
essential during immune development for commensal flora-induced priming but the 
presence of MyD88 is dispensable during the actual inflammatory challenge.  To test 
this hypothesis, we used the MyD88 flox/- ROSA26-Cre/Esr+/- (cKO) mice 211 to 
conditionally eliminate MyD88 just before challenge with zymosan. In these mice, one 
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allele of the gene had been deleted from the germline while the other could be inducibly 
deleted globally by the administration of tamoxifen. Mice were treated with tamoxifen 
for three alternate days and challenged with zymosan a week after the last tamoxifen 
injection. Therefore, in these mice MyD88 was reduced at the time of zymosan 
injection, but present during the maturation of the immune system.  Upon 
administration of tamoxifen, MyD88 was deleted as assessed by QPCR, as described 
previously 212 (Table 2.1). cKO mice treated with tamoxifen (one week before zymosan 
challenge) responded as well as untreated mice to zymosan-induced peritonitis (Figure 
2.13 A). These results showed that the presence of MyD88 is not essential for the 
signaling initiated by zymosan. While the deletion of MyD88 was partial in these 
animals, they showed reduced neutrophil recruitment to LPS, confirming the role of the 
TLR4-MyD88 pathway in detecting LPS and also validating that the deletion was 
sufficient to impair responses (Figure 2.13 B). In contrast, tamoxifen treatment of wild 
type mice did not impair responses (data not shown).  On the other hand, when cKO 
mice when treated with tamoxifen from Day 0 of birth, these mice exhibited reduced 
neutrophil recruitment to zymosan as compared to untreated mice (Figure 2.13 C). 
These results supported our hypothesis that for inflammatory ligands like zymosan, 
MyD88 is required during the pre-challenge phase for activation of immune cells but is 
dispensable during the actual inflammatory challenge. 
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Table 2.1 
Tamoxifen Treatment Tissue ΔΔCt Residual myd88flox % Deletion 
Starting from birth Blood 1.625 0.324 67.57 
Peritoneal cells 1.835 0.280 71.97 
Starting from a week 
   before zymosan       
challenge 
Blood 0.97 0.510 48.94 
Peritoneal cells 0.923 0.527 47.25 
 
Table 2.1: Deletion efficiency in Myd88flox/- Rosa26-Cre/ESR+/- mice (cKO) 
The amount of residual floxed MyD88 after treatment with tamoxifen was determined 
by qPCR. 
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Figure 2.13 
 
 
Figure 2.13: MyD88 is required during the conditioning of the immune system for 
a subsequent zymosan challenge rather than during the actual zymosan challenge  
(A- B) Total neutrophil numbers in the peritoneum of MyD88-/flox Rosa26-Cre/ESR+/- 
(cKO) which have been treated with tamoxifen or corn oil (vehicle control) one week 
before challenge with (A) 0.2 mg zymosan and (B) 100 ng LPS. (C) Total neutrophil 
numbers in the peritoneum of MyD88-/flox Rosa26-Cre/ESR+/- (cKO) which have been 
treated with tamoxifen or corn oil (vehicle control) starting from birth and challenged 
with 0.2 mg zymosan at 7 weeks of age. Mice were lavaged at 4 h after injection with 
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zymosan or LPS and the numbers of neutrophils in the peritoneum was quantified by 
flow cytometry. All data are combined results of two experiments and represented as 
mean ± SEM. n = Total number of mice used per datum group. The PBS group 
represents cKO mice treated with tamoxifen and challenged with PBS and lavaged after 
4 h. * P = 0.04, ** P = 0.004, Not significant (N.S.) versus cKO animals that were 
treated with vehicle control and injected with zymosan or LPS.  
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We hypothesized that microbial flora was functioning in our system as a source of 
PAMPs that stimulated the TLR-MyD88-pathway in ways that made the host 
responsive  
to the proinflammatory stimuli. This argument was supported by our observation that 
when mice were treated with antibiotics starting from birth for 45 days, they had 
lowered neutrophil migration, but 6-week old mice treated with antibiotics for the same 
duration (45 days) did not show a similar defect in neutrophil migration (data not 
shown). This finding suggested that initial exposure to microbes or microbial ligands 
might be sufficient to prime neutrophil responses. To test this hypothesis, we sought to 
determine if MyD88 activation by a purified microbial ligand is sufficient to restore 
neutrophilic inflammation to zymosan in antibiotic-treated mice. We added pure 
lipopolysaccharide (LPS) from E.coli into the drinking water of mice from 3-5 weeks 
of age in addition to the antibiotic cocktail. We found that antibiotic-treated mice, 
which received LPS for 2 weeks, were able to respond to zymosan as well as their SPF 
counterparts (Figure 2.14). On the other hand, antibiotic-treated MyD88 knockout mice 
did not show this restoration in inflammation on LPS administration (Figure 2.14). This 
shows that MyD88 is required for the downstream signaling initiated by LPS, which 
enables acute inflammation. 
 
 
 
 
80
Figure 2.14 
 
 
Figure 2.14: LPS pre-treatment in antibiotic-treated mice prior to zymosan 
challenge restores neutrophilic inflammation in process dependent upon MyD88-
signaling  
Total neutrophil numbers after zymosan injection in the peritoneum of SPF C57BL/6 
and antibiotic-treated C57BL/6 mice and antibiotic-treated MyD88-/- mice in the 
presence of absence of LPS pre-stimulation. LPS from Escherichia coli was 
administered in the drinking water of mice at a concentration of 33 mg/L from 3-5 
weeks of age. At 7 weeks of age, mice injected with 0.2mg zymosan and lavaged after 
4h. In one group, antibiotic-treated mice were pre-treated with LPS in the drinking 
water but did not receive zymosan injection. All data are combined results of two or 
more experiments and represented as mean ± SEM. * P =0.03, Not significant (N.S.) 
versus SPF animals. 
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2.3. Discussion 
One of the major findings of this study is that for neutrophil-mediated acute 
inflammation to several proinflammatory agents, the immune system needs to be 
previously stimulated by intestinal flora in a MyD88-dependent fashion (Figure 2.15). 
This stimulation enables the host to mount a neutrophil response to future inflammatory 
insults. We have shown that germ-free and antibiotic-treated mice are defective in 
neutrophil migration to a number of different microbial and sterile inflammatory 
ligands. This defect can be corrected by supplementing the drinking water with LPS, a 
TLR4-MyD88 agonist, prior to challenge with the inflammatory agent. Furthermore, 
pre-treatment of antibiotic-treated MyD88 knockout mice with LPS failed to restore 
neutrophilic infiltration, showing that LPS specifically acts through MyD88 to prime 
the immune system.  
A previous report published by our laboratory had shown that MyD88 knockout mice 
do not show a defect in zymosan-induced neutrophil migration197. The basis for this 
discrepancy is unclear. One likely possibility is that the mice used in the previous study 
were inadvertently exposed to some TLR stimulation, such as LPS, e.g. in their housing 
environment, drinking water or chow; as we show here, exposure to LPS and 
presumably other TLR agonists p.o. for a short period is sufficient to reverse the 
phenotype of antibiotic-treated mice that of conventional mice. It is also possible that 
this difference was due to the extent of backcrossing of the MyD88-deficient mice; the 
mice in the present study were fully backcrossed onto the B6 background whereas those 
in the earlier study were not. 
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Figure 2.15 
 
 
 
Figure 2. 15: Model depicting the role of gut flora in regulating the acute 
inflammatory response  
(1) Bacterial ligands derived from intestinal flora enter tissues via the bloodstream, 
where they prime tissue-resident cells through MyD88 signaling 
(2) This MyD88-dependent priming enables the extravasation of neutrophils into the 
tissue upon receiving an inflammatory signal. 
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While there is a clear role for MyD88 in the ability of conventional mice to mount 
neutrophilic inflammation to zymosan, we found that several other innate immune 
signaling pathways were not required for this response. Although Clarke et al. have 
reported that commensal bacteria prime neutrophils via NOD1 signaling in ways that 
enhance their phagocytic potential to various bacteria191, we found that RIP2 knockout 
mice did not show reduced inflammation to zymosan. Since RIP2 is required for 
NOD1/2 signaling, this finding argued against a role for either NOD1 or NOD2 in 
mediating gut flora-induced priming134. Therefore, NOD1/2 signaling may be important 
for phagocytosis but is not needed for neutrophilic inflammation to this agent.  
Similarly, we found little contribution of the inflammasome components 
(Nalp3/Asc/caspase-1) or the RNA-sensing RIG-I Like Receptors (RLRs) in mediating 
zymosan-induced inflammation. Hence, we show that intestinal flora prime the immune 
system, specifically via MyD88 pathway.  
Recent studies by Ganal et al. and Abt et al. also show that intestinal flora prime tissue-
resident cells so that they are better equipped to mount a future immune response213,214. 
By employing a genome-wide transcriptional profile, Abt et al. reported that peritoneal 
macrophages from untreated antibiotic-treated mice show lower expression of genes 
involved in antiviral immunity as compared to those from SPF mice213. Ganal et al. 
further show that in TLR-stimulated splenic DCs isolated from germ free mice, 
production and nuclear translocation of NF-κB and IRF3 was unimpaired, but they 
failed to bind to their respective cytokine promoters214. Consequently, the germ free 
mice-derived splenic DCs made less IFN-I than their SPF counterparts after poly 
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(I:C)/LPS stimulation. Although our study supports the general notion of gut flora 
priming the systemic immunity, we found that antibiotic-treated mice are not impaired 
in their production of inflammatory cytokines (like TNFα, MIP-2, and KC) in the 
peritoneum after zymosan challenge. In fact, we found significantly higher amounts of 
proinflammatory cytokines including MIP-2 and KC in the peritoneal fluid in the 
antibiotic-treated mice as compared to the SPF mice.  
The finding that the antibiotic-treated mice were producing even higher levels of MIP-2 
(and other proinflammatory cytokines) than control mice, yet were defective in 
inflammation, was surprising because these animals showed normal inflammatory 
responses to injected MIP-2. This indicated that upon zymosan challenge something 
was interfering with the ability of the antibiotic-treated mice to respond to the cytokines 
they were producing. This is reminiscent of some earlier studies by Souza et al., 
Fagundes et al., and Amaral et al. that found that germ free mice overproduced IL-10, 
which could inhibit immune responses192-194. They show that neutralizing IL-10 with 
antibodies could restore responses in germ free mice to levels of conventional mice. 
However, in our system, while anti-IL-10 did increase responses in the antibiotic-
treated mice, it did not restore their responses to the level of control mice treated with 
anti-IL10. Therefore, our data indicate that there must be other anti-inflammatory 
factors that are inhibiting responses in the absence of microbial stimulation. This anti-
inflammatory activity affects inflammation by multiple stimuli including ones that are 
IL-1-dependent (e.g. silica) and IL-1-independent (zymosan). It will be of interest in 
future studies to define the nature of this activity. 
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An implication of our study is that the set point of the unperturbed innate immune 
system maybe anti-inflammatory for many stimuli. However, in conventionally reared 
mice the immune system is perturbed by exposure to microbial flora. As part of this 
process MyD88-dependent pattern recognition receptor signaling by microbial flora 
appears to alter this set point in ways that promote inflammatory responses. 
In summary, we postulate that TLR ligands derived from the intestinal flora 
constitutively enter the blood and into tissues. Here, they prime tissue-resident cells via 
MyD88-signaling, so that they provide appropriate stimulatory signals for neutrophil 
migration to future inflammatory insults. This study provides insights on how intestinal 
flora affects systemic immunity and specifically innate responses against pathogens and 
sterile agents. 
 
2.4. Material and Methods 
Mouse Strains: SPF C57BL/6 mice and IL-1R-/- mice were purchased from The Jackson 
Laboratories (Bar Harbor, ME). Germ-free C57BL/6 mice were obtained from The 
National Gnotobiotic Rodent Resource Center (P40RR018603 and P30 DK 34987), 
North Carolina State University Gnotobiotics Unit and Gnotobiotic Research Resource, 
Medical University of South Carolina. MyD88-/- mice were provided by Dr. Shizuo 
Akira, Osaka University, Osaka, Japan or purchased from The Jackson Laboratories. 
RIP2-/- mice were provided by Dr. Michelle Kelliher and RIG-I-/- and MDA5-/- mice 
were provided by Dr. Kate Fitzgerald (University of Massachusetts Medical School, 
Worcester). NOD1-/- mice were provided by Dr. Grace Chen, University of Michigan, 
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Ann Arbor, MI. For generating the tamoxifen-inducible deletion mutant mice of 
MyD88, we used a strategy similar to the one described previously 211. MyD88-/- mice 
were crossed to the whole tissue, tamoxifen-inducible Cre transgenic mice (Rosa26-
Cre/ESR+/+) (provided by Dr. Roger Davis, University of Massachusetts Medical 
School, Worcester). The resultant offsprings, MyD88+/- Rosa26-Cre/ESR+/- mice were 
crossed to the MyD88flox/flox mice (provided by Dr. Robert Finberg, University of 
Massachusetts Medical School, Worcester) to generate the MyD88-/flox Rosa26-
Cre/ESR+/- (cKO). Animals were housed and handled according to protocols approved 
by the University of Massachusetts animal care and use committee. 
Peritonitis: Mice were injected intraperitoneally with 0.2 mg zymosan (Sigma-Aldrich, 
St. Louis, MO) or 0.5 mg silica crystals (Sigma-Aldrich, St. Louis, MO) or 0.5 mg 
MSU crystals or 1 ug recombinant mouse MIP-2 (R&D, Minneapolis, MN) in 0.2 ml 
PBS. For the thioglycollate injections, 1 ml of 3% thioglycollate (Thermoscientific, 
Lenexa, KS) was used. MSU crystals were prepared as described before 215. 4-16 h after 
the injection, mice were euthanized by exposure to isoflourane. The peritoneum was 
lavaged with 2 mL DMEM with 2% FCS, 3 mM EDTA, and 10 U/ml heparin. The 
peritoneal cells were stained with antibodies against mouse Ly-6G, CD11b (both from 
BD Bioscience, San Jose, CA), 7/4, F4/80 (both from eBioscience, San Diego, CA). 
The percentage and absolute numbers of different cell types was determined by flow 
cytometric analysis and cell counting beads (Life Technologies, Grand Island, NY). 
FACS analysis was performed using a BD Biosciences LSRII Flow cytometer and 
FlowJo (Tree Star) analysis software. Supernatants from peritoneal lavage were used 
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for cytokine quantitation by ELISA. ELISAs for the cytokines TNFα, and IL-10 were 
performed using kits purchased from eBioscience and those for MIP-2 and KC were 
performed using kit from R&D (Minneapolis, MN). In other experiments, cells from 
bone marrow and blood were analyzed and quantified by flow cytometry.  
Intestinal flora depletion using antibiotics: C57BL/6 and MyD88-/- mice were treated 
with a cocktail of broad- spectrum antibiotics in their drinking water starting from birth 
to the time they were used in experiments as described before 208. The antibiotic 
cocktail consisted of ampicillin 1 g/L, neomycin 1 g/L, metronidazole 1 g/L (Sigma-
Aldrich, St. Louis, MO), and vancomycin 0.5 g/L (PhytoTechnology Laboratories, KS). 
The artificial aspartame sweetener, Equal (Merisant Company, Chicago, IL) was added 
to the water 5 g/L to make it palatable for the mice to drink. Pups received the 
antibiotics indirectly via lactating mothers till they were weaned. Drinking water 
containing the antibiotics was replaced every week.  
16S rRNA quantification: DNA was isolated from colonic contents of mice by the 
DNeasy Blood and Tissue Kit (Quigen, Hilden, Germany). The qPCR primers used to 
amplify the bacterial 16S V2 region were sense, 5’- AGYGGCGIACGGGTGAGTAA; 
and antisense, 5’- CYIACTGCTGCCTCCCGTAG.  qPCR primers used to amplify the 
housekeeping gene GAPDH were sense 5’-TGATGGGTGTGAACCACGAG;  and 
antisense 5’- TCAGTGTAGCCCAAGATGCC-3. qPCR reaction was performed using 
the iQ SYBR Green supermix on the CFX96 Touch Bio-rad machine. The PCR cycling 
reaction used was 15 min activation step (95°C); 35 cycles of 30 s denaturation (95°C), 
30 s annealing (60°), and 30 s extension (72°C). 
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LPS treatment: LPS from Escherichia coli, serotype 026:B6, purified by gel-filtration 
chromatograph (Sigma Aldrich, St. Louis, MO) was administered in the drinking water 
of mice at a concentration of 33 mg/L from 3-5 weeks of age. 
Antibody neutralizing experiments: Mice were treated with an intraperitoneal injection 
of IL-10R antibody (Clone 1B1.3A) or control antibody ((HRPN), both purchased from 
Bio X Cell (New Lebanon, NH)), 16 h and 3 h before zymosan challenge, 0.25 mg 
antibody per mouse each time. Mice were lavaged 4 h after zymosan injection and 
analyzed for neutrophil numbers in their peritoneum as described before. 
Tamoxifen-induced deletion of MYD88: Tamoxifen (Sigma-Aldrich, St. Louis, MO) 
solution was prepared in corn oil (Sigma-Aldrich, St. Louis, MO) at 10 mg/mL by 
incubating at 37ºC for 2 h. To induce deletion of floxed genes in adult mice, tamoxifen 
(50 mg/kg of body weight) was administered to floxed mice by oral gavage for three 
alternate days. Mice were used in experiments 7 days after the last administration. For 
treating pups, lactating mothers were treated intraperitoneally with tamoxifen (200 
mg/kg of body weight) from the day of birth for 5 consecutive days.  
QPCR to detect deletion of floxed MYD88 gene: The efficiency of deletion of floxed 
MyD88 allele was assessed using Taqman PCR using primers and method described 
previously 212. The PCR cycling reaction was performed on the C1000 Thermal Cycler 
(Bio-Rad). 
Phagocytosis Assay: Efficiency of phagocytosis by peritoneal cells was assessed as 
described before 216.  Briefly, FITC-conjugated zymosan (0.8 mg/ml) was prepared in 
DMEM + 20% FBS. Peritoneal cells plated at 0.5 million cells/well of a 48-well plate 
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were incubated with 500 µl of the FITC-conjugated zymosan solution for 45 min at 
37°C. The reaction was terminated by transferring the plate to 0°C. The uningested 
zymosan was removed by washing wells with HBSS. Cells were scraped off the plate 
and resuspended in 2 mg/ml trypan blue to quench cell surface-bound zymosan. In the 
control group, cells were incubated with zymosan at 0°C throughout the incubation. 
The efficiency of phagocytosis, ‘phagocytosis index,’ was calculated as % of F4/80 
cells that were FITC+ X MFI of F4/80 cells. 
Statistical analyses: Data are reported as means ± SEM. Statistical analysis in each 
independent experiment was performed with an unpaired, two-tailed Student t test. 
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CHAPTER 3 
 
 
 
 
IDENTIFICATION OF THE CELLULAR SOURCE OF IL-1 IN 
CELL DEATH-INDUCED INFLAMMATION 
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3.1. Introduction 
Cell death is a potent activator of inflammation82. The discovery of cell injury and cell 
death as triggers of the inflammatory response happened long before that of microbe-
stimulated inflammation. However, as compared to pathogen-driven inflammatory 
responses, very little is known about how cell death triggers inflammation.  
Several explanations have been proposed to explain why cell necrosis is a likely 
inducer of inflammation. Firstly, cell death could be a consequence of an invading 
pathogen. Some bacteria like Mycobacterium tuberculosis and Shigella flexneri induce 
cell death in the host tissue217,218. Hence, by recruiting neutrophils to the site of cell 
death, the host immune system is actually helping in clearing the infection. Secondly, 
cell death may be an indicator of some “unhealthy” cellular condition like tumor. In all 
these cases, the inflammatory response helps to limit the extent of prevailing damage 
by diluting away the injurious agents, removing the noxious stimuli by promoting 
phagocytosis of the cell debris and/or walling off the problem. 
In some cases, the cell death-mediated inflammatory response might prove to be a 
double-edged sword to the host. In the ensuing inflammatory response, the resident and 
recruited cells and their secreted molecules help in eliminating or containing the tissue 
injury and promoting tissue regeneration. But often this response is non-specific, 
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leading to bystander tissue damage. This is evident from the fact that cell death-induced 
inflammation contributes to pathogenesis of various diseases like myocardial infarction, 
and trauma injury219. Hence, an in-depth understanding of this process becomes critical 
in identifying therapeutic targets for these diseases. 
The inflammatory response to cell death is mediated by a number of endogenous 
molecules. These non-microbial, host cell-derived ligands are called Danger Associated 
Molecular Patterns (DAMPs). Such molecules are normally encased in the plasma 
membrane, hence hidden from immune surveillance. Some of the known DAMPs have 
been described in the introduction of this thesis. Different DAMPs may be more or less 
contributory depending upon the type of injury and the type of tissue involved.  
To study how cell death signals the recruitment of neutrophils, mice genetically lacking 
different receptors and signaling molecules were used197. The TLRs were potential 
candidates for sensing cell death because of their ability to detect a variety of bacteria-
derived ligands and their wide tissue expression. Furthermore, they are located either 
on the cell surface or on the endosomal membrane, which places them in a strategic 
location to detect injured tissue or phagocytized dead cells. However, the single 
knockout mice for TLR1, TLR3, TLR6, TLR7, TLR9, and TLR11 were as efficient as 
wild type mice in recruiting neutrophil migration to dead cells. Mice doubly deficient in 
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TLR2 and TLR4 showed a modest decrease in dead cell-induced neutrophil infiltration. 
Therefore, it was found that individual TLRs played only a minor role in dead cell-
induced acute inflammation.  
Next, the role of the TLR adaptor proteins was assessed by using mice deficient in 
these proteins. Single knockout mice of TIRAP, TRIF, and TRAM showed no defect in 
dead cell-elicited inflammation. However, MyD88 was essential for the inflammatory 
response to dead cells. MyD88 is an adaptor protein for the TLR, IL-1R, and IL-18 
signaling pathways. Given the modest contribution of TLRs to dead cell-induced 
inflammation, the role of IL-1R and IL-18 was examined. It was found that IL-1R 
deficient animals had a profound reduction in neutrophil recruitment to dead cells. The 
role of IL-1 signaling was further confirmed by using mice doubly deficient in IL-1α 
and IL-1β.  
The term IL-1 refers to a group of three polypeptides, IL-1α, IL-1β and IL-1 receptor 
antagonist (IL-1Ra) each of which is encoded by a separate but homologous gene220,221. 
Both IL-1α and IL-1β signal through the same receptor IL-1R1 and have identical 
biological activities in solution. IL-1Ra is a competitive inhibitor of IL-1α and IL-1β 
for receptor binding222. IL-1α is cell membrane-bound and is believed to act locally. 
Both IL-1 α and IL-1β have wide tissue expression including hematopoietic cells like 
macrophages and monocyte and non-hematopoietic cells like keratinocytes and 
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endothelial cells. IL-1 promotes the initial inflammatory response by triggering the 
release of histamine from mast cells. In addition, they act as potent endogenous 
pyrogens by stimulating the synthesis of prostaglandin E2 from the vascular 
endothelium of hypothalamus. It also stimulates the production of collagenase and 
PGE2 by synovial cells223. The latter has been attributed to the joint damage observed 
in the chronic inflammatory disease, rheumatoid arthritis223. 
Despite similar functions, there are differences in the expression of IL-1α and IL-1β 
and how the activity of these molecules is regulated. IL-1β is secreted and circulates 
systematically. Secondly, IL-1β has an amino terminal pro-domain which needs to be 
cleaved by the inflammasomes, to generate the functional protein. In contrast, IL-1α 
has an amino terminal pro-domain, which is cleaved by proteases, but this is not 
required for its biological activity221 
IL-1R is expressed on many cell types, including both leukocytes and parenchymal 
cells such as epithelium, endothelium, fibroblasts, and smooth muscle cells224. IL-1α or 
Il-1β bind to the cytosolic immunoglobulin, ligand-binding domain of the receptor. 
This leads to the recruitment of a second receptor subunit, the IL-1R accessory protein 
(IL-1RAcP). The formation of the receptor heterodimer induces signaling, by 
recruitment of downstream signaling proteins like myeloid differentiation primary 
response protein (MyD88), through the cytosolic Toll/IL-1 receptor (TIR) domain225. 
Because of its potency and extensive functions, the activity of IL-1α and IL-1β is 
tightly controlled.  
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Since IL-1 has a wide tissue expression, further studies to establish the cellular source 
of IL-1 were needed to unravel the mechanism of cell death-triggered inflammatory 
response. Experiments described in this section, helped address this question. 
 
3.2. Results  
Dying cells are not a significant source of IL-1 during cell-death induced inflammatory 
response 
Both IL-1α and IL-1β are expressed by a variety of tissues226. Expression of both the 
isoforms is enhanced by NF-κB-induced transcriptional upregulation to generate a 31-
kDa precursor protein. Pro-IL-1β is further processed by the inflammasome machinery 
to generate its secreted, functionally active form. Unlike IL-1β, IL-1α exists in three 
compartments, pro-IL-1α (intracellular), myristoylated form of proIL-1a (membrane-
bound), and mature IL-1α (secreted form). All the three forms of IL-1α are biologically 
active. 
Since cells contain intracellular pools of active pro-IL-1α, it is possible that upon cell 
death they release the cytokine passively. IL-1 α released in this fashion may be 
sufficient to induce neutrophil migration. This idea was supported by a recent study by 
Eigenbrod et al227. The alternate hypothesis is that certain tissue-resident cells detect 
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certain DAMPs released from the necrotic cells and produce IL-1 after activation. To 
address the question of whether IL-1 is sourced from the dying cells or the responding 
host tissue, mice lacking IL-1α or both IL-1α and IL-1β were used either as donors of 
tissue homogenates or as hosts. 
Necrotic tissue homogenates from either wild type or IL-1α deficient hosts were 
injected intraperitoneally into wild type hosts and the ensuing neutrophilic 
inflammation was determined (Figure 3.1 A, B, C). There was no reduction in the 
inflammatory response to the IL-1α deficient homogenates as compared to the wild 
type tissue homogenates.  To eliminate the possibility that this is a tissue-specific 
effect, homogenates from a variety of tissue origins like heart (Figure 3.1 A), liver 
(Figure 3.1 B) and brain (Figure 3.1 C) was tested, but in each case, the IL-1α deficient 
homogenates showed no reduction. Since dying cells could also secrete IL-1β that 
might contribute to inflammation, we also examined tissues from IL-1αβ double-
deficient animals (Figure 3.1 D, E, F). The pro-inflammatory activity of brain (Figure 
3.1 D), liver (Figure 3.1 E), and heart (Figure 3.1 F), from IL-1α-/-β-/- was equivalent to 
wild type tissues, when injected in wild type host.  
The above results implied that necrotic tissues were not a significant source of IL-1 
during inflammation. The method of inducing death; thermal or mechanical disruption  
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Figure 3.1 
 
 
 
 
 
Figure 3.1: Requirement of IL-1 released from dying cells for neutrophil 
recruitment  
A-C, Necrotic brain homogenate (A), liver homogenate (B), or heart homogenate (C) 
from C57BL/6 (WT) or IL-1α-/- mice were injected i.p. into C57BL/6 mice. Total 
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neutrophil number in the peritoneal cavity was measured 14 h post injection. D–F, 
Total neutrophil number in the peritoneal cavity of C57BL/6 mice in response to i.p. 
injected necrotic brain homogenate (D), liver homogenate (E), or heart homogenate (F) 
derived from C57BL/6 (WT) or IL-1α-/-β-/- mice. All data are combined results of three 
or more experiments and represented as means ± SEM (n = total number of mice from 
the multiple experiments for each group). PBS groups, WT mice received i.p. PBS. 
*p<0.05, N.S., not significant, versus WT group. 
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Figure 3.2 
 
 
 
 
 
 
Figure 3.2: Method of inducing cell death has no effect on the requirement of IL-1 
from the injured tissue 
Total neutrophil number in the peritoneal cavity of C57BL/6 mice after 14 hours of i.p. 
injection with heat-shocked single cell suspension of liver cells from C57BL/6 (WT) or 
IL-1α-/- mice. The data are combined results of three experiments and represented as 
means ± SEM (n = total number of mice from the multiple experiments for each group). 
PBS groups, WT mice received i.p. PBS. N.S., not significant, versus WT group. 
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had no effect on the phenotype observed. There was no reduction in inflammation to 
liver homogenate, which was generated by thermal injury from IL-1α-/- mice (Figure 
3.2). We next determined if the host cells were the source of IL-1, by using mice that 
were lacking IL-1α or IL-1β or both. We tested the neutrophilic migration to the 
secondary cell line, EL4, which had been killed by thermal incubation or nitrogen 
cavitation (Figure 3.3 A). In line with our hypothesis, the dead cell-mediated 
inflammation was completely inhibited in host mice lacking both IL-1α/IL-1β. In fact, 
even single knockout hosts (IL-1α-/- or IL-1β-/-) showed significant reduction in 
neutrophil migration to dead EL4s. This data stressed the importance of these cytokines 
in sterile injury as well as confirmed the fact that most of the IL-1 required during 
inflammation is host-derived. Furthermore, to show that this finding is physiologically 
relevant, we showed that the response of IL-1α-/-β-/- mice to necrotic liver homogenate 
is significantly reduced as compared to wildtype hosts (Figure 3.3 B).  
How does the above finding reconcile with data shown by Eigenbrod et al227? Similar 
to the experiments performed in this paper, we saw that when necrotic IL-1 α-/- or IL-
1α-/-β-/- dendritic cells were used as the stimuli in wildtype hosts, they had reduced 
capacity to recruit neutrophils as compared to wildtype necrotic bone marrow dendritic 
cells (BMDC) (Figure 3.4 A, B). This finding indicated that in certain cell types like 
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dendritic cells, the necrotic cells themselves could be a source of IL-1. However, even 
in this case, the host contributes to the IL-1 pool as exemplified by the fact that necrotic 
dendritic cell-inflammation is partially reduced in IL-1α-/-β-/- hosts (Figure 3.4 C). 
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Figure 3.3 
 
Figure 3.3. Host-derived IL-1 is required for neutrophil recruitment to dead cells 
(A) Total neutrophil number of peritoneal cavity 14 h after i.p. injection of heat-
shocked necrotic EL4 cells in C57BL/6 WT, IL-1α-/-, IL-1β-/-, IL-1α-/-β-/-, or IL-1R-/-. 
One-way ANOVA and Bonferroni’s multiple comparison tests were used to compare 
all of the groups. There were no significant differences among groups of IL-1α-/-, IL-1β-
/-, IL-1α-/-β-/-, or IL-1R-/- (not indicated in the figure). (B) WT C57BL/6-derived liver 
homogenate was injected i.p. into C57BL/6 or IL-1α-/-β-/-mice. The total neutrophil 
number of peritoneal cavity 14 h after i.p. injection are shown. All of them are 
combined results of three or more experiments and represented as means ± SEM (n = 
total number of mice from the multiple experiments for each group). PBS groups, WT 
mice received i.p. PBS. ***p < 0.001, versus WT group. 
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Figure 3.4 
 
 
Figure 3.4: Both host-derived and dead cell-derived IL-1 is contributing to 
neutrophil recruitment to necrotic BMDCs 
(A, B) The total neutrophil numbers in peritoneal cavity of WT C57BL/6 mice after 14 
h i.p. injection of heat-shocked necrotic BMDCs from WT and IL-1α-/- (A) or IL-1α-/-β-/- 
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(B) mice. (C) The total neutrophil numbers in peritoneal cavity of WT C57BL/6 or IL-
1α-/-β-/- mice after 14 h i.p. injection of heat-shocked necrotic BMDCs from WT mice. 
All the data displays are combined results of three or more experiments and represented 
as means ± SEM (n = total number of mice from the multiple experiments for each 
group). ***p < 0.001; **p < 0.01; *p < 0.05, NS versus WT group (A–C). 
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The above data that necrotic dendritic cells are a source of IL-1, suggested that live 
dendritic cells have preformed IL-1, which gets released upon cell death. This led to the 
hypothesis that live dendritic cells themselves are inflammatory, by virtue of their 
existent IL-1 pool. This idea was supported by the finding that live dendritic cells were 
as inflammatory as necrotic ones (Figure 3.5 A). Furthermore, neutrophil recruitment to 
live dendritic cells requires the presence of IL-1α and IL-1β (Figure 3.5 B). However, 
dendritic cells are an exception because in the case of other cells, for e.g., (Figure 3.5 
C), live cells fail to elicit inflammation. 
Hematopoietic cells release IL-1 in response to cell death 
The next step was to examine the nature of this host-derived cell. To broadly 
characterize if the IL-1 secreting cell was bone marrow- derived or parenchymal in 
origin, bone marrow chimeras were made. It was seen that the inflammatory response 
to dead cells was reduced substantially but not completely in radiation chimeras, whose 
bone marrow lacked both IL-1α and IL-1β. This showed that hematopoietic or bone 
marrow derived cells are the significant contributors of these cytokines, though non-
hematopoietic cells play a minor role (Figure 3.6 A). We sought to confirm this 
observation by using hosts deficient in IL-1α and/or IL-1β and wildtype animals as 
bone marrow donors. This experiment demonstrates that IL-1α is entirely derived from 
bone marrow-derived cells. On the other hand, IL-1β is derived from bone marrow and 
in a smaller degree from parenchymal cells (Figure 3.6 B). 
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Figure 3.5 
 
 
Figure 3.5: Live BMDCs are capable of eliciting neutrophil recruitment in a IL-
1α/IL-1β dependent way 
(A) The total neutrophil numbers in peritoneal cavity of WT C57BL/6 mice after 4 h 
108
i.p. injection of indicated number (million) of live or heat-shocked necrotic BMDCs 
from WT mice. (B) The total neutrophil numbers in peritoneal cavity of WT C57BL/6 
mice after 4 h i.p. injection of 5 million of live BMDCs from WT or IL-1α-/-β-/-  mice. 
(C) The total neutrophil numbers in peritoneal cavity of WT C57BL/6 mice after 4 h 
i.p. injection of live or heat-shocked necrotic EL4 cells. The small amount of 
inflammation seen after injection of live EL4 is presumably due a small number of dead 
cells in the injected suspension. All the data displays are combined results of three or 
more experiments and represented as means ± SEM (n = total number of mice from the 
multiple experiments for each group). ***p < 0.001; *p < 0.05, NS versus WT group 
(B) or same amount of necrosis group (A, C). 
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Figure 3.6 
 
 
Figure 3.6: Bone marrow-derived cells are the major producer of IL-1 in 
inflammation to dead cells  
(A) Total neutrophil numbers in peritoneal cavity were determined in bone marrow 
chimeric mice 14 h after i.p. challenge of heat-shocked necrotic EL4 cells. Chimeric 
mice were generated using C57BL/6 (WT) mice as hosts and the indicated IL-1-/- mice 
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(IL-1α-/-, IL-1β-/- or IL-1α-/-β-/-) as donors or using IL-1-/- mice as hosts and IL-1-/- mice 
(IL-1α-/-, IL-1β-/- or IL-1α-/-β-/-) as donors. (B) Total neutrophil numbers in the 
peritoneal cavity were determined in bone marrow chimeric mice 14 h after i.p. 
challenge of heat-shocked necrotic EL4 cells. Chimeric mice were generated by using 
IL-1-/- mice as hosts and C57BL/6 WT mice as donors. All the data displays are 
combined results of three or more experiments and represented as means ± SEM (n = 
total number of mice from the multiple experiments for each group. (A) One-way 
ANOVA and Bonferroni’s multiple comparison test for all of the groups showed a 
significant difference for WT >WT to all the other groups (p <0.001), but there was no 
significant difference among the groups of cells from IL-1-/- donors (not shown in the 
figure). B, Bonferroni’s multiple comparison test for all the groups showed a significant 
difference for WT > IL-1 α-/- to WT > IL-1β-/-, IL-1 α-/- > IL-1 α-/- or IL-1β-/- > IL-1β-/- 
(p<0.01, not shown in the figure). ***p < 0.001; **p < 0.01, NS versus EL4 stimulated 
WT greater than WT group. stim, stimulated. 
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3.3. Discussion 
Cell-death induced neutrophilic inflammation is important for the clearance of the cell 
debris and resolution of the wound. On the other hand, in some cases, neutrophil 
infiltration can actually exacerbate the existing cell injury. Indeed, this is observed in 
the case of pathological conditions like ischemic damage to the heart, lung, liver, brain, 
and kidney. Considering the physiological impact of dead cell-induced inflammation, 
very little is known about the molecular and cellular “messengers” which propagate 
signals from dying cells in a tissue to neutrophils in the bone marrow and blood. The 
current study addresses some of these questions.  
Previous work in the laboratory had demonstrated the requirement of IL-1 for 
mediating cell-death induced inflammation. The role of IL-1 in cell injury related 
neutrophil recruitment was more significant than that of other pro-inflammatory 
cytokines like TNFα228. Furthermore, neutrophilic inflammation to the yeast cell wall 
component, zymosan was not diminished in IL-1R-/- mice. This exemplified the specific 
role of IL-1 in propagating inflammation triggered by cell injury but not microbes. 
Further information regarding the source of IL-1 was needed.   
An important finding of this study is that in most cases, the injured tissue is not a major 
contributor of IL-1α that is required to propagate the inflammatory signal. On the 
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contrary, IL-1α/IL-1β is generated by hematopoietic host cells, in response to sterile 
injury. Exceptions to this rule may be cells, which make high quantities of IL-1α, even 
when they are alive. In this study, IL-1α deficient dendritic cells, whether alive or dead 
showed substantially reduced neutrophilic inflammation as compared to wild-type cells. 
However, even in this instance, some part of the required IL-1α/IL-1β was sourced 
from host tissue. This supports the idea that there exist some host responding cells, 
which relay the inflammatory signal from injured tissues to blood neutrophils, via the 
secretion of IL-1.  
A favored model is that the injured tissue releases DAMPs, which bind to cognate 
receptors on tissue-resident cells, which have hematopoietic origins. The latter, once 
activated are the source of IL-1. To identify this bone marrow derived tissue resident 
sensor of cell injury, a series of cell depletion studies were performed153. These studies 
revealed that the initiation of an acute inflammatory response to sterile cell death 
requires a CD11bhigh leukocyte that is almost certainly macrophage. This conclusion 
was supported by the finding that conditionally depleting CD11b-positive cells in mice 
inhibited these responses.  
In summary, necrotic tissues are not a significant source of the cytokines IL-1α/IL-1β in 
the context of the inflammatory response. Rather, bone marrow-derived cells, most 
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likely macrophages are the primary sensors and producers of IL-1α during cell death-
induced inflammation. 
 
3.4. Material and Methods 
Animal and cell lines: Wild-type (WT) C57BL/6 mice were purchased from The 
Jackson Laboratory (Bar Harbor, ME). IL-1α, IL-1β, and IL-1αβ double-deficient mice 
of C57BL/6 background were described previously229. Irradiated bone marrow 
chimeras was prepared as described215. All animal protocols were approved by the 
University of Massachusetts animal care and use committee. EL4 cells were maintained 
in RPMI-1640 with 10% FCS and antibiotics. All the cultured cell lines are tested 
negative for mycoplasma (Lonza, Basel, Switzerland). 
Preparation of necrotic cells: Bone marrow-derived dendritic cells (BMDCs) were 
obtained from cultures of bone marrow cells of C57BL/6 or IL-1–deficient mice with 
IL-4 (10 ng/ml, Invitrogen, San Diego, CA) and GM-CSF (5 ng/ml, Invitrogen) in 
Hybridoma culture medium for 7 d. A single-cell suspension of liver was obtained by 
collagenase type IV treatment as previously described230. To induce necrosis from 
thermal injury, BMDCs, liver or EL4 cells were washed five times with PBS, then 
resuspended in PBS at 10 million cells/50 µl, and then heat shocked at 45°C for 10 min, 
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followed by 37°C incubation for 5 h; this resulted in necrosis (7-aminoactinomycin 
D/propidium iodide positive cells). After thermal injury, there were no viable cells 
observed by microscopy with trypan blue staining. 
To induce mechanical necrosis, brain, liver, or heart from C57BL/6 or IL-1–deficient 
mice were weighed and added with five times of weight of PBS and subjected to 
mechanical injury by a motor-driven tissue tearer, followed by nitrogen cavitation for 
10 min at 500 pounds per square inch. Similarly, mechanical necrosis was induced in 
EL4 and BMDCs by nitrogen cavitation for 10 min at 500 pounds per square inch. 
After mechanical injury, no viable cells were seen by microscopy and when analyzed 
by flow cytometry typically 99.9% of the cells were disrupted into fragments. The 
resulting necrotic cell suspensions were used for experiments without any clarification 
(i.e., containing all released cellular components and debris). 
Neutrophil recruitment to peritoneal cavity: Mice were injected i.p. with 5 million 
necrotic BMDCs in 500 µl PBS, 30 million of necrotic EL4 cells in 150 µl PBS, 150 µl 
liver homogenate, or 500 µl heart or brain homogenate unless otherwise indicated. The 
total protein amounts in necrotic cell preparations that were injected were 4.1 mg 
dendritic cells (DCs), 12.6 mg (EL4), 72.4 mg (brain), 25.4 mg (liver), or 77.0 mg 
(heart). The amount of the necrotic DCs, brain, liver, and heart preparations that was 
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injected was one that was determined to induce a non-maximal response so as to be on 
a sensitive portion of the dose response curve. After 13–15 h of injection, the 
peritoneum was lavaged with 6 ml PBS with 2% FCS, 3 mM EDTA, and 10 U/ml 
heparin. The absolute number of neutrophil (Ly-6G+ 7/4+) in 100µl lavage was counted 
using flow cytometer equipped with a high throughput sampler (BD Bioscience). 
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4.1. Introduction 
Neutrophil recruitment to dead cells is critically dependent upon IL-1 signaling197. The 
role of IL-1 signaling in sterile inflammation was conclusively shown using mice 
deficient in IL-1R as well as those doubly deficient in IL-1α and IL-1β. The previous 
chapter describes the experiments undertaken to identify the cellular source of IL-1. 
Another area of research was to elucidate the downstream events of IL-1 signaling. 
Previous work in the laboratory showed that non-hematopoietic cells are the cellular 
targets of IL-1197. This was based on results obtained from IL-1R bone marrow 
chimeric mice.  Wild-type (WT) mice that were reconstituted with IL-1R–deficient 
bone marrow (Il1r-/-  WT) did not show any significant reduction in inflammatory 
responses to necrotic cells. In contrast, IL-1R–deficient mice reconstituted with wild-
type bone marrow (WT  Il1r-/-) had markedly reduced inflammatory responses to 
dead cells. Therefore, the IL-1R expression was required on radioresistant (non–bone-
marrow-derived or parenchymal), but not radiosensitive (bone marrow–derived or 
hematopoietic) host cells for them to respond to IL-1.  
To elucidate the key cellular target of IL-1 in cell death-induced inflammation, we 
proposed to generate the conditional knock out mouse for IL-1R. This would be 
achieved by making the Il-1r floxed mouse, in which loxP sites flank the protein-
encoding exon. The intervening sequence between the loxP sites can be deleted by 
recombination mediated by the enzyme Cre recombinase. This is enabled by crossing 
the floxed mice with mice expressing Cre recombinase under the control of promoters 
specific to parenchymal tissues. Examples of the parenchymal tissues, which are likely 
119
to be targets of IL-1 signaling, are the endothelium, epithelium, fibroblasts, and smooth 
muscle. Our favored hypothesis is that the endothelium is the major IL-1 target, 
because it controls the recruitment of neutrophils into tissues. However, it is likely that 
there are different IL-1 signaling targets in different tissue sites and pathological 
conditions.  
 
4.2. Research design and methods 
We obtained two independent BAC clones containing the chromosomal sequences of 
the IL-1R of 129Sv origin from the BACPAC Resource Center, Children's Hospital 
Oakland Research Institute, California, USA (Figure 4.1). Since the genomic sequence 
of this strain is not available in databases, we sequenced both BAC clones 3 times each. 
With this information, we amplified the suitable fragments and designed a targeting 
vector as described below.  
Construction of the targeting vector: The strategy used for constructing the targeting 
vector is based on the design of the vector described previously to generate the straight 
knock out mice of IL-1R231. This strategy has been shown to completely abrogate IL-
1R expression and function, without affecting the viability of the mice, hence it has 
been validated already. It involves targeted Cre-mediated deletion of the loxP site-
flanked exon 2 of the Il-1r locus. This exon encodes the signal peptide of the mature 
protein (Figure 4.2) and also contains a possible ATG initiation codon. The deleted 
mutant after homologous recombination, would not encode a functional protein because 
the signal peptide is absent and the other potential upstream ATG would be out of  
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Figure 4.1 
Figure 4.1: Map of the BAC clone used to sequence and amplify the Il-1r gene 
fragments  
The numerals denote the position on Chromosome 1. Exon 2, which would be deleted 
in the knockout mouse and its chromosomal position, is denoted in blue.  
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Figure 4.2 
 
 
Figure 4.2: The endogenous Il-1r gene locus (top) and the corresponding mature 
protein domain structure (bottom)  
Each numbered box in the Il-1r genome represents an exon.  Each box in the protein 
structure represents a distinct domain. The color code indicates the different exons 
encoding distinct domains of the mature protein. The exons in black represent 
untranslated regions. 
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frame when fused to downstream exons. The downstream ATG if used, would result 
into a highly truncated protein without a signal peptide. 
The construction of the vector in brief, was as follows (Figure 4.3). The 4.6kb long 
MscI-XmnI fragment which contained sequence 5’ to the targeted Exon 2 was 
amplified from the BAC clone and cloned in SacII site of the ploxPIII-neo-lTK plasmid 
(a gift from Dr.Joonsoo Kang, University of Massachusetts Medical School, 
Worcester). The 3.3kb long amplified XmnI- SwaI fragment, which contained sequence 
3’ of the targeted Exon 2 was cloned in the PmeI site of the above vector. Finally the 
0.4kb XmnI-XmnI fragment encompassing the Exon 2 was cloned in the AscI site, to 
get the complete targeting vector. The vector already contained the 3-loxP sites and 
PGK-Neo (encoding the neomycin resistance gene) and the HSV-TK (encoding the 
thymidine kinase gene, conferring susceptibility to ganciclovir) cassettes, which would 
be used for positive and negative selection respectively, as described in the following 
paragraph. 
Selection of correctly integrated ES cell clones: The construct was linearized by MluI 
and electroporated into 129Sv embryonic stem (ES) cells. The actual electroporation 
and the subsequent blastocyst injections were performed by the UMass Knock out Core 
Facility. The cells were grown in media containing neomycin and ganciclovir for 
selection of cells, which have undergone homologous recombination with the correct 
arm of the targeting construct. Initially the DNA from the individual ES cells was 
digested with BamHI and analyzed by Southern Blot analysis with a 300bp probe as  
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Figure 4.3 
Figure 4.3: Schematic representation of the targeting vector (bottom figure) and 
the corresponding elements in the endogenous Il-1r locus (top figure).  
The dotted lines indicate the fragments used in construction of the vector.  MscI, XmnI, 
and SwaI are the restriction sites that were used for cloning. 
 
124
Figure 4.4 
Figure 4.4: Southern Blotting strategy to identify targeted allele 
The expected band pattern of the wildtype (WT) (top figure) and the targeted alleles of 
the il-1r locus (bottom figure), after BamH1 digestion and hybridization with 3’ probe. 
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Figure 4.5 
Figure 4.5: Floxed PCR strategy to identify targeted allele 
Only the clones carrying the targeted allele would show the expected band (4.3kb) after 
PCR with the above primers. 
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shown in the figure (Figure 4.4). The wild type genome was identified as a 14.4kb 
band. The targeted allele was distinguished by the presence of a shorter 8.4kb band, 
because of the introduction of a BamHI site by the integrated vector construct. Out of 
300 ES cell clones screened, 8 were found to be homologous recombinants for the 
targeting construct. The presence of the targeted allele in these clones was further 
confirmed by a nested PCR (Figure 4.5) 
Out of these 8 targeted clones, 2 were chosen for subsequent electroporation with the 
CMV- Cre plasmid (which encodes Cre recombinase gene), with the goal of removing 
the neo cassette. Since there are three possible outcomes of the in vitro Cre-mediated 
excision, the clones in which neo cassette has been specifically deleted, while leaving 
the Exon 2 intact, were screened by PCR (Figure 4.6). Out of the 200-screened clones, 
consistent with the expected recombination frequency, 1/3rd were found to have 
undergone the correct recombination event. 3 of these correctly recombined clones 
were used for injection in blastocyst and further implantation into mice to generate the 
chimeras.  
 
Breeding the chimeric mice: The 129Sv ES cells had the locus for agouti coat color and 
were injected into C57BL/6 non-agouti blastocysts. These blastocysts were implanted 
into white, non-agouti C57BL/6 mothers. The resultant pups were chimeric and could 
be identified by the presence of brown hairs on a white background. Higher degree of 
chimerism generally indicates a greater chance of germline transmission of the  
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Figure 4.6Figure 4.6.1:
Figure 4.6.2:
Figure 4.6: PCR strategy to identify the correctly recombined clone  
Treatment of targeted clones (From figure 4.5) with Cre recombinase leads to three 
possible genomic recombination events (Figure 4.6.1). The heterozygous ‘desired’ 
recombined allele was identified using PCR (Figure 4.6.2) 
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transgenic 129Sv cells. We obtained several mice with a high percentage of chimerism 
(>70%). These mice were used for breeding with black non-agouti C57BL/6 mice. 
After multiple rounds of breeding, we have been able to obtain agouti pups that have 
one copy of the transgenic 129Sv genome.  
 
4.3. Future Directions 
Breeding the conditional knockout mice: The agouti pups heterozygous for the floxed 
il-1r gene are presently been bred to get homozygous offsprings.  The latter, which are 
on the 129Sv background will be backcrossed 10 generations onto the C57BL/6 
background.  
The next step would be to generate mice that lack the IL-1R only on their vascular 
endothelium. This will be accomplished by mating the Floxed-IL-1R mice with 
transgenic mice expressing the cre recombinase under the control of an endothelial 
specific promoter. There are several such transgenic mice available, e.g., mice 
expressing cre under the control of Tie-1, Tie-2 and Flk promoters and have been used 
successfully to make endothelial-specific knock out mice232-234. We plan to use the 
Tie2-cre mice because they work uniformly in embryonic and adult stages. We will 
verify the selective excision of the IL-1R by assaying for the expression of the IL-1R in 
endothelium and other cells by immunohistochemistry and PCR on cells isolated by 
laser capture microscopy. The cre-transgene will be eliminated through breeding and 
mice homozygous for the endothelial IL-1R knock out will be bred. 
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Testing the conditional IL-1R - deficient mice for their neutrophilic inflammation to 
dead cells: The goal of this project is to test the hypothesis that the vascular 
endothelium is the parenchymal target of IL-1 that is required for the death-induced 
acute inflammatory response. To this end, we will compare the inflammatory response 
between wild type and the endothelial tissue- specific IL-1R knock out mice, in 
different tissues to cell death. In all these assays, the sterile inflammatory response has 
been shown to be IL-1R dependent.  
It is possible that the endothelium will not be the key target of IL-1 in the cell death-
induced inflammatory pathway. If this is what is found in our analysis of the 
endothelial IL-1R knock out mice, we will investigate other potential parenchymal 
targets. Specifically we would next investigate the role of the IL-1R in fibroblasts and 
smooth muscle using tissue-specific cre expressing mice. The rationale for these targets 
is that the IL-1-dependent death-induced inflammatory response is seen when dead 
cells are injected s.c. and the principal parenchymal cells in this location are fibroblasts 
and smooth muscle. Moreover, both of these cell types express IL-1R. 
If neutrophilic inflammation were still intact in these mutant animals then we would 
consider testing other parenchymal targets like epithelial cells using cell type specific 
cre-mediated deletion. If there is a partial phenotype seen in the tissue-specific 
knockouts, we will consider creating a double/triple conditional knockout. 
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5. GENERAL DISCUSSION 
The present study about the regulation of inflammation by commensal flora 
demonstrates for the first time that gut resident bacteria are absolutely essential for the 
extravasation of neutrophils from blood into the inflamed tissues. Our favored model is 
that in the absence of intestinal flora (or in the default state), the host immune system 
makes some anti-inflammatory factor(s) either constitutively or after inflammatory 
activation. In other words, in the absence of priming by endogenous flora, the host is in 
a state of inhibited neutrophilic inflammation. On the other hand, in the presence of 
intestinal flora, this inhibitory “brake” on inflammation is released, facilitating 
neutrophil migration upon receiving an appropriate stimulus. However, our data does 
not eliminate the possibility that in the absence of intestinal flora, the host fails to make 
some essential pro-inflammatory molecule(s). This scenario would also cause the 
observed generalized defect in neutrophil migration.  
The major future goal is to determine this factor, which is either upregulated in germ-
free mice (if it is an inhibitory factor) or downregluated in germ-free mice (if it is a pro-
inflammatory factor). We aim to perform a microarray study using peritoneal 
macrophages from zymosan-stimulated SPF or germ-free mice. We propose that 
macrophages are good candidates for these studies because previous work in the 
laboratory has shown that these cells are the primary sensors for various inflammatory 
stimuli153. Once this factor is identified, further confirmatory experiments will be done 
using antibody blocking experiments (similar to the experiment performed to assess the 
role of IL-10 in acute inflammation). 
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We have also shown that the intestinal flora-mediated regulation of acute inflammation 
requires MyD88 signaling. We propose that MyD88 stimulation though any of the TLR 
agonists released from resident bacteria is sufficient to prime neutrophilic responses. 
Hence, single knockout mice for each of the TLRs are capable of stimulating neutrophil 
migration, because these mice can still ligate MyD88 through other TLRs. The 
systemic release of microbial ligands from resident pathogens appears to be a powerful 
means by which they can exert widespread effects on host immunity and possibly other 
aspects of physiology. Indeed, Clarke et al have demonstrated that peptidoglycan 
released from stably colonized E. coli translocates from the gut mucosa into the blood 
stream191. However, additional direct evidence of other bacterial products in the 
circulation and distal tissues that have originated from endogenous microbes, in the 
absence of a breach in intestinal epithelium is desired.  
Another unresolved question is which MyD88-expressing cell types are the targets of 
intestinal flora priming. We propose to create bone marrow chimeras to broadly 
understand if it’s the parenchymal/hematopoietic compartment, which requires the 
expression of MyD88 to propagate zymosan-induced peritonitis.  Also, an adoptive 
transfer of peritoneal cells from wildtype or MyD88-/- mice into wildtype or MyD88-/- 
mice would help address the question if it were the peritoneal cells, which require the 
presence of MyD88. Based on our observation that neutrophils can immigrate to a MIP-
2 injection in the peritoneum, we propose that lack of MyD88 activation by resident 
flora does not affect the neutrophils per se. Rather, there is a defect in the activation of 
some other MyD88-expressing cell which acts upstream of neutrophil migration in the 
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inflammatory signaling pathway.  
Yet another area of investigation would be to identify which species of the intestinal 
flora is crucial for priming neutrophil migration. Treatment of mice with a single 
antibiotic (for e.g., ampicillin or neomycin) can help identify if it is a specific class of 
bacteria (gram-positive or gram-negative bacteria) that is mediating the phenotype. 
However, our initial experiments using single antibiotic treatments instead of a cocktail, 
did not implicate a single class of bacteria as the primary mediator of inflammation. 
Another convenient tool to investigate the role of specific intestinal bacterial residents 
mice is the process of mono-colonization. Mono-colonization of germ-free animals is 
the process of reconstituting them with a single bacterial species. Several recent studies 
have implicated particular resident bacteria in the establishment of a specific aspect of 
immunity235. Germ-free mice colonized with known prominent species of the resident 
flora will be tested for their inflammatory responses. 
There is a possibility that the commensal flora-MyD88 signaling axis is essential for 
other aspects of neutrophil production and migration. Previous studies have shown that 
the release of neutrophils from bone marrow into blood stream during inflammatory 
conditions is independent of MyD88 signaling236. However, MyD88 may influence the 
blood-tissue transit of neutrophils by regulating the expression of certain cell adhesion 
molecules, which are crucial for neutrophil infiltration into tissues. We have shown that 
neutrophils from antibiotic-treated mice have similar expression of CXCR2, the 
receptor of MIP-2 and KC and cell adhesion molecules like CD62L and CD44. But it is 
possible that the expression of other cell adhesion molecules is affected in antibiotic-
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treated mice. This can be determined by a performing a quantitative PCR of putative 
adhesion molecules from isolated endothelial cells and neutrophils. The commensal 
flora-MyD88 signaling axis might affect neutrophil homeostasis in terms of its survival 
in the peripheral tissue. We saw that in antibiotic-treated mice, the numbers of 
neutrophils in the peritoneum are lower than that in SPF mice even at earlier time 
points (as early as 45 min after zymosan challenge). Also, the total numbers of dead 
cells in the peritoneum were not higher in antibiotic-treated mice as compared to SPF 
mice after zymosan challenge. This data argued against the possibility that neutrophils 
are being recruited into tissues in antibiotic-treated mice but are dying sooner than in 
SPF mice.  
Another likelihood is that the production of G-CSF and GM-CSF is impaired in the 
absence of commensal flora. The defect shown in this study appears specifically in the 
immigration of neutrophils into inflamed tissues. Previous papers have shown that these 
two cytokines are dispensable for the neutrophil influx into tissues, which suggests that 
impaired production of G-CSF/GM-CSF is unlikely to be the cause of the observed 
defect8. However, a quantitative estimation of these cytokines in the blood stream of 
antibiotic-treated mice after inflammation would be more conclusive to rule out the role 
of G-CSF/GM-CSF in this phenotype. 
We observed that in the germ-free mice, there were much higher amounts of pro-
inflammatory cytokines (TNFα, MIP-2, and KC) in the peritoneum than in SPF mice, in 
spite of having fewer neutrophils. This could possibly be because of lack of negative 
regulation of cytokine expression by infiltrating neutrophils in the peritoneum. 
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Neutrophils upon immigrating into the site of injury, undergo rapid apoptosis (as early 
as 2h). The apoptotic neutrophils are then cleared by tissue-resident macrophages, 
promoting the resolution of inflammation237. Shibata et al have shown that early 
apoptotic neutrophils inhibit the production of cytokines like TNFα, IL-6, MIP-2 from 
macrophages in vitro238. Also, in an in vitro co-culture model, neutrophils have been 
shown to inhibit the secretion of IL-1β and TNFα from peripheral blood mononuclear 
cells239. The absence of infiltrating neutrophils in the germ-free mice could explain the 
higher levels of peritoneal cytokines in these mice. 
Probiotics is a term given to live organisms, which restore the host intestinal flora 
balance, replacing the harmful bacteria with “good” ones. Some strains of bacteria have 
been approved by research for treatment of specific gastrointestinal disorders, based on 
strong, positive, well conducted and controlled studies240. Examples of such disorders 
include antibiotic and non-antibiotic associated diarrhea and Clostridium difficile-
associated diarrhea. However, there is no evidence for the application of probiotics for 
general immune strengthening.  
Our research might explain why administration of probiotics is not effective in 
reversing systemic immune pathologies caused by intestinal flora imbalance. The 
“good” bacteria in the probiotic cultures might be effective in displacing the unhealthy 
bacteria restoring intestinal homeostasis. However, the priming effected by virulence 
factors or other ligands released from the harmful bacteria might still persist in the 
system, triggering the undesirable immune pathology. This argument was supported by 
our observation that when mice were treated with antibiotics starting from birth for 45 
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days, they had lowered neutrophil migration, but 6-week old mice treated with 
antibiotics for the same duration (45 days) did not show a similar defect in neutrophil 
migration. This finding suggested that initial exposure to microbes or microbial ligands 
might be sufficient to prime neutrophil responses. Similarly, a short exposure of 
antibiotic-treated mice to a MyD88 ligand was sufficient to restore inflammation in 
these mice, in spite of the fact that there was no MyD88 stimulation at the time of 
inflammatory challenge. In the same way, effect of the immune priming triggered by 
pathogens might be long term and irreversible.  
In summary, this study demonstrates that the hype regarding the use of probiotic 
cultures to treat a myriad of immune diseases needs to be viewed with caution. 
However, modulation of the intestinal flora at a younger age in humans might be more 
successful in protecting individuals from immune pathologies in adulthood and needs to 
be assessed in future studies.  
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